CN101473953B - Fabricated food for cleaning blood and expelling toxin as well as method for processing the same and application - Google Patents
Fabricated food for cleaning blood and expelling toxin as well as method for processing the same and application Download PDFInfo
- Publication number
- CN101473953B CN101473953B CN2008102290573A CN200810229057A CN101473953B CN 101473953 B CN101473953 B CN 101473953B CN 2008102290573 A CN2008102290573 A CN 2008102290573A CN 200810229057 A CN200810229057 A CN 200810229057A CN 101473953 B CN101473953 B CN 101473953B
- Authority
- CN
- China
- Prior art keywords
- blood
- vitamin
- meal
- small
- food
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 210000004369 blood Anatomy 0.000 title claims abstract description 159
- 239000008280 blood Substances 0.000 title claims abstract description 159
- 235000013305 food Nutrition 0.000 title claims abstract description 123
- 238000012545 processing Methods 0.000 title claims abstract description 58
- 239000003053 toxin Substances 0.000 title claims abstract description 12
- 231100000765 toxin Toxicity 0.000 title claims abstract description 12
- 238000000034 method Methods 0.000 title claims description 19
- 238000004140 cleaning Methods 0.000 title abstract description 34
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims abstract description 22
- 239000011734 sodium Substances 0.000 claims abstract description 22
- 229910052708 sodium Inorganic materials 0.000 claims abstract description 22
- 235000005686 eating Nutrition 0.000 claims abstract description 13
- 238000003672 processing method Methods 0.000 claims abstract description 8
- 235000016709 nutrition Nutrition 0.000 claims description 121
- 235000012054 meals Nutrition 0.000 claims description 118
- 230000035764 nutrition Effects 0.000 claims description 109
- 239000000843 powder Substances 0.000 claims description 73
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 claims description 64
- 239000011591 potassium Substances 0.000 claims description 59
- 229910052700 potassium Inorganic materials 0.000 claims description 59
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 57
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 56
- 239000002994 raw material Substances 0.000 claims description 55
- 235000013325 dietary fiber Nutrition 0.000 claims description 51
- 229940088594 vitamin Drugs 0.000 claims description 50
- 239000011782 vitamin Substances 0.000 claims description 50
- 239000000047 product Substances 0.000 claims description 49
- 239000000835 fiber Substances 0.000 claims description 43
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims description 42
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 claims description 39
- 239000011651 chromium Substances 0.000 claims description 39
- 229910052804 chromium Inorganic materials 0.000 claims description 39
- 235000012721 chromium Nutrition 0.000 claims description 39
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 claims description 39
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 claims description 38
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 37
- 238000002560 therapeutic procedure Methods 0.000 claims description 36
- 235000005911 diet Nutrition 0.000 claims description 35
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims description 34
- 239000001103 potassium chloride Substances 0.000 claims description 32
- 235000011164 potassium chloride Nutrition 0.000 claims description 32
- 235000010755 mineral Nutrition 0.000 claims description 31
- 239000011707 mineral Substances 0.000 claims description 31
- 238000002156 mixing Methods 0.000 claims description 31
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 31
- 229930003231 vitamin Natural products 0.000 claims description 31
- 235000013343 vitamin Nutrition 0.000 claims description 31
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims description 28
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 27
- 235000005282 vitamin D3 Nutrition 0.000 claims description 27
- 239000011647 vitamin D3 Substances 0.000 claims description 27
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 claims description 27
- 229940021056 vitamin d3 Drugs 0.000 claims description 27
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims description 23
- 239000011777 magnesium Substances 0.000 claims description 23
- 229910052749 magnesium Inorganic materials 0.000 claims description 23
- 235000010323 ascorbic acid Nutrition 0.000 claims description 22
- 229960005070 ascorbic acid Drugs 0.000 claims description 22
- 239000011668 ascorbic acid Substances 0.000 claims description 22
- 239000011724 folic acid Substances 0.000 claims description 22
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims description 21
- 229960000304 folic acid Drugs 0.000 claims description 21
- 235000019152 folic acid Nutrition 0.000 claims description 21
- 235000015424 sodium Nutrition 0.000 claims description 21
- 239000001913 cellulose Substances 0.000 claims description 20
- 229920002678 cellulose Polymers 0.000 claims description 20
- 235000010469 Glycine max Nutrition 0.000 claims description 19
- 244000068988 Glycine max Species 0.000 claims description 19
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 claims description 19
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 19
- 235000011194 food seasoning agent Nutrition 0.000 claims description 19
- 235000008160 pyridoxine Nutrition 0.000 claims description 19
- 239000011677 pyridoxine Substances 0.000 claims description 19
- 235000019157 thiamine Nutrition 0.000 claims description 19
- 229960003495 thiamine Drugs 0.000 claims description 19
- 239000011721 thiamine Substances 0.000 claims description 19
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 claims description 19
- 229930003799 tocopherol Natural products 0.000 claims description 19
- 235000010384 tocopherol Nutrition 0.000 claims description 19
- 229960001295 tocopherol Drugs 0.000 claims description 19
- 239000011732 tocopherol Substances 0.000 claims description 19
- 229940011671 vitamin b6 Drugs 0.000 claims description 19
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 claims description 19
- 239000000203 mixture Substances 0.000 claims description 18
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 claims description 17
- 229920002752 Konjac Polymers 0.000 claims description 17
- 235000010485 konjac Nutrition 0.000 claims description 17
- 235000019192 riboflavin Nutrition 0.000 claims description 17
- 229960002477 riboflavin Drugs 0.000 claims description 17
- 239000002151 riboflavin Substances 0.000 claims description 17
- 235000007319 Avena orientalis Nutrition 0.000 claims description 15
- 239000011716 vitamin B2 Substances 0.000 claims description 15
- 239000000796 flavoring agent Substances 0.000 claims description 14
- 238000004519 manufacturing process Methods 0.000 claims description 14
- 239000003921 oil Substances 0.000 claims description 14
- 235000019198 oils Nutrition 0.000 claims description 14
- 238000004806 packaging method and process Methods 0.000 claims description 14
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims description 14
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims description 13
- 235000003434 Sesamum indicum Nutrition 0.000 claims description 13
- 229910052711 selenium Inorganic materials 0.000 claims description 13
- 239000011669 selenium Substances 0.000 claims description 13
- 235000011649 selenium Nutrition 0.000 claims description 13
- 239000011573 trace mineral Substances 0.000 claims description 13
- 235000013619 trace mineral Nutrition 0.000 claims description 13
- 239000011726 vitamin B6 Substances 0.000 claims description 13
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 12
- 235000003255 Carthamus tinctorius Nutrition 0.000 claims description 12
- 244000020518 Carthamus tinctorius Species 0.000 claims description 12
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 12
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 12
- 239000011575 calcium Substances 0.000 claims description 12
- 229910052791 calcium Inorganic materials 0.000 claims description 12
- 235000001465 calcium Nutrition 0.000 claims description 12
- 230000000378 dietary effect Effects 0.000 claims description 12
- 238000001035 drying Methods 0.000 claims description 11
- 239000003623 enhancer Substances 0.000 claims description 11
- GSZUGBAEBARHAW-UHFFFAOYSA-N sophoraflavone B Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C=2OC3=CC(O)=CC=C3C(=O)C=2)C=C1 GSZUGBAEBARHAW-UHFFFAOYSA-N 0.000 claims description 11
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 11
- 235000021307 Triticum Nutrition 0.000 claims description 10
- 229930003270 Vitamin B Natural products 0.000 claims description 10
- 240000008042 Zea mays Species 0.000 claims description 10
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims description 10
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 10
- 235000005822 corn Nutrition 0.000 claims description 10
- PXEDJBXQKAGXNJ-QTNFYWBSSA-L disodium L-glutamate Chemical compound [Na+].[Na+].[O-]C(=O)[C@@H](N)CCC([O-])=O PXEDJBXQKAGXNJ-QTNFYWBSSA-L 0.000 claims description 10
- 235000013923 monosodium glutamate Nutrition 0.000 claims description 10
- 229940073490 sodium glutamate Drugs 0.000 claims description 10
- 235000019156 vitamin B Nutrition 0.000 claims description 10
- 239000011720 vitamin B Substances 0.000 claims description 10
- 239000011701 zinc Substances 0.000 claims description 10
- 229910052725 zinc Inorganic materials 0.000 claims description 10
- 235000016804 zinc Nutrition 0.000 claims description 10
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 claims description 9
- KSDSYIXRWHRPMN-UHFFFAOYSA-N 4'-O-beta-D-Galactopyranoside-6''-p-Coumaroylprunin-4',5,7-Trihydroxyflavanone Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C2OC3=CC(O)=CC(O)=C3C(=O)C2)C=C1 KSDSYIXRWHRPMN-UHFFFAOYSA-N 0.000 claims description 9
- 244000247812 Amorphophallus rivieri Species 0.000 claims description 9
- 235000001206 Amorphophallus rivieri Nutrition 0.000 claims description 9
- DEMKZLAVQYISIA-ONJCETCRSA-N Liquiritin Natural products O([C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1)c1ccc([C@@H]2Oc3c(C(=O)C2)ccc(O)c3)cc1 DEMKZLAVQYISIA-ONJCETCRSA-N 0.000 claims description 9
- DEMKZLAVQYISIA-UHFFFAOYSA-N Liquirtin Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C2OC3=CC(O)=CC=C3C(=O)C2)C=C1 DEMKZLAVQYISIA-UHFFFAOYSA-N 0.000 claims description 9
- 229930003427 Vitamin E Natural products 0.000 claims description 9
- 230000033228 biological regulation Effects 0.000 claims description 9
- RMRCNWBMXRMIRW-BYFNXCQMSA-M cyanocobalamin Chemical compound N#C[Co+]N([C@]1([H])[C@H](CC(N)=O)[C@]\2(CCC(=O)NC[C@H](C)OP(O)(=O)OC3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)C)C/2=C(C)\C([C@H](C/2(C)C)CCC(N)=O)=N\C\2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O RMRCNWBMXRMIRW-BYFNXCQMSA-M 0.000 claims description 9
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 9
- 235000012907 honey Nutrition 0.000 claims description 9
- 239000000252 konjac Substances 0.000 claims description 9
- DEMKZLAVQYISIA-ZRWXNEIDSA-N liquiritin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C([C@H]2OC3=CC(O)=CC=C3C(=O)C2)C=C1 DEMKZLAVQYISIA-ZRWXNEIDSA-N 0.000 claims description 9
- 239000000845 maltitol Substances 0.000 claims description 9
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 claims description 9
- 235000010449 maltitol Nutrition 0.000 claims description 9
- 229940035436 maltitol Drugs 0.000 claims description 9
- 235000018102 proteins Nutrition 0.000 claims description 9
- 102000004169 proteins and genes Human genes 0.000 claims description 9
- 108090000623 proteins and genes Proteins 0.000 claims description 9
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 claims description 9
- 235000019165 vitamin E Nutrition 0.000 claims description 9
- 239000011709 vitamin E Substances 0.000 claims description 9
- 229940046009 vitamin E Drugs 0.000 claims description 9
- 235000016425 Arthrospira platensis Nutrition 0.000 claims description 8
- 240000002900 Arthrospira platensis Species 0.000 claims description 8
- 235000000832 Ayote Nutrition 0.000 claims description 8
- 235000009854 Cucurbita moschata Nutrition 0.000 claims description 8
- 235000009804 Cucurbita pepo subsp pepo Nutrition 0.000 claims description 8
- 102000015636 Oligopeptides Human genes 0.000 claims description 8
- 108010038807 Oligopeptides Proteins 0.000 claims description 8
- 244000228451 Stevia rebaudiana Species 0.000 claims description 8
- 150000001720 carbohydrates Chemical class 0.000 claims description 8
- 235000003599 food sweetener Nutrition 0.000 claims description 8
- 239000008187 granular material Substances 0.000 claims description 8
- 235000013336 milk Nutrition 0.000 claims description 8
- 239000008267 milk Substances 0.000 claims description 8
- 210000004080 milk Anatomy 0.000 claims description 8
- 235000015136 pumpkin Nutrition 0.000 claims description 8
- 229940082787 spirulina Drugs 0.000 claims description 8
- 239000003765 sweetening agent Substances 0.000 claims description 8
- 240000004244 Cucurbita moschata Species 0.000 claims description 7
- 240000008620 Fagopyrum esculentum Species 0.000 claims description 7
- 235000009419 Fagopyrum esculentum Nutrition 0.000 claims description 7
- 239000004519 grease Substances 0.000 claims description 7
- 238000005728 strengthening Methods 0.000 claims description 7
- 239000013589 supplement Substances 0.000 claims description 7
- 229960003080 taurine Drugs 0.000 claims description 7
- 239000011718 vitamin C Substances 0.000 claims description 7
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 claims description 6
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 6
- AANLCWYVVNBGEE-IDIVVRGQSA-L Disodium inosinate Chemical compound [Na+].[Na+].O[C@@H]1[C@H](O)[C@@H](COP([O-])([O-])=O)O[C@H]1N1C(NC=NC2=O)=C2N=C1 AANLCWYVVNBGEE-IDIVVRGQSA-L 0.000 claims description 6
- 235000019774 Rice Bran oil Nutrition 0.000 claims description 6
- 229930003268 Vitamin C Natural products 0.000 claims description 6
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 claims description 6
- 239000001506 calcium phosphate Substances 0.000 claims description 6
- 229910000389 calcium phosphate Inorganic materials 0.000 claims description 6
- 235000011010 calcium phosphates Nutrition 0.000 claims description 6
- 235000014633 carbohydrates Nutrition 0.000 claims description 6
- 235000015165 citric acid Nutrition 0.000 claims description 6
- 235000013890 disodium inosinate Nutrition 0.000 claims description 6
- 229910052742 iron Inorganic materials 0.000 claims description 6
- 235000011090 malic acid Nutrition 0.000 claims description 6
- 239000001630 malic acid Substances 0.000 claims description 6
- 230000008569 process Effects 0.000 claims description 6
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 claims description 6
- 239000008165 rice bran oil Substances 0.000 claims description 6
- 235000005713 safflower oil Nutrition 0.000 claims description 6
- 239000003813 safflower oil Substances 0.000 claims description 6
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 claims description 6
- 235000019154 vitamin C Nutrition 0.000 claims description 6
- 235000008599 Poria cocos Nutrition 0.000 claims description 5
- 235000019485 Safflower oil Nutrition 0.000 claims description 5
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 claims description 5
- 238000001816 cooling Methods 0.000 claims description 5
- 239000011666 cyanocobalamin Substances 0.000 claims description 5
- 235000000639 cyanocobalamin Nutrition 0.000 claims description 5
- 235000013312 flour Nutrition 0.000 claims description 5
- 235000013355 food flavoring agent Nutrition 0.000 claims description 5
- 238000010438 heat treatment Methods 0.000 claims description 5
- 230000001007 puffing effect Effects 0.000 claims description 5
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 claims description 5
- 229940013618 stevioside Drugs 0.000 claims description 5
- 235000019202 steviosides Nutrition 0.000 claims description 5
- 239000011691 vitamin B1 Substances 0.000 claims description 5
- 241000371652 Curvularia clavata Species 0.000 claims description 4
- UDIPTWFVPPPURJ-UHFFFAOYSA-M Cyclamate Chemical compound [Na+].[O-]S(=O)(=O)NC1CCCCC1 UDIPTWFVPPPURJ-UHFFFAOYSA-M 0.000 claims description 4
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 claims description 4
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 claims description 4
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 claims description 4
- 235000009508 confectionery Nutrition 0.000 claims description 4
- 229960002104 cyanocobalamin Drugs 0.000 claims description 4
- 239000000625 cyclamic acid and its Na and Ca salt Substances 0.000 claims description 4
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 4
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 claims description 4
- 229960000367 inositol Drugs 0.000 claims description 4
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 claims description 4
- 239000008159 sesame oil Substances 0.000 claims description 4
- 235000011803 sesame oil Nutrition 0.000 claims description 4
- 229960001462 sodium cyclamate Drugs 0.000 claims description 4
- 238000005507 spraying Methods 0.000 claims description 4
- 238000003756 stirring Methods 0.000 claims description 4
- 235000011044 succinic acid Nutrition 0.000 claims description 4
- 239000001384 succinic acid Substances 0.000 claims description 4
- 235000002906 tartaric acid Nutrition 0.000 claims description 4
- 239000011975 tartaric acid Substances 0.000 claims description 4
- WBZFUFAFFUEMEI-UHFFFAOYSA-M Acesulfame k Chemical compound [K+].CC1=CC(=O)[N-]S(=O)(=O)O1 WBZFUFAFFUEMEI-UHFFFAOYSA-M 0.000 claims description 3
- 241001289529 Fallopia multiflora Species 0.000 claims description 3
- 235000001188 Peltandra virginica Nutrition 0.000 claims description 3
- 244000000231 Sesamum indicum Species 0.000 claims description 3
- 235000010358 acesulfame potassium Nutrition 0.000 claims description 3
- 229960004998 acesulfame potassium Drugs 0.000 claims description 3
- 239000000619 acesulfame-K Substances 0.000 claims description 3
- UDMBCSSLTHHNCD-KQYNXXCUSA-N adenosine 5'-monophosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O UDMBCSSLTHHNCD-KQYNXXCUSA-N 0.000 claims description 3
- 235000019658 bitter taste Nutrition 0.000 claims description 3
- 229940088597 hormone Drugs 0.000 claims description 3
- 239000005556 hormone Substances 0.000 claims description 3
- 241001107116 Castanospermum australe Species 0.000 claims description 2
- 241000427324 Glinus Species 0.000 claims description 2
- FURUXTVZLHCCNA-UHFFFAOYSA-N Liquiritigenin Natural products C1=CC(O)=CC=C1C1OC2=CC(O)=CC=C2C(=O)C1 FURUXTVZLHCCNA-UHFFFAOYSA-N 0.000 claims description 2
- 241000206607 Porphyra umbilicalis Species 0.000 claims description 2
- 235000021279 black bean Nutrition 0.000 claims description 2
- 235000007215 black sesame Nutrition 0.000 claims description 2
- 239000003795 chemical substances by application Substances 0.000 claims description 2
- JBQATDIMBVLPRB-UHFFFAOYSA-N isoliquiritigenin Natural products OC1=CC(O)=CC=C1C1OC2=CC(O)=CC=C2C(=O)C1 JBQATDIMBVLPRB-UHFFFAOYSA-N 0.000 claims description 2
- FURUXTVZLHCCNA-AWEZNQCLSA-N liquiritigenin Chemical compound C1=CC(O)=CC=C1[C@H]1OC2=CC(O)=CC=C2C(=O)C1 FURUXTVZLHCCNA-AWEZNQCLSA-N 0.000 claims description 2
- 244000248825 Peltandra virginica Species 0.000 claims 1
- 244000098338 Triticum aestivum Species 0.000 claims 1
- 239000002131 composite material Substances 0.000 claims 1
- 239000007788 liquid Substances 0.000 claims 1
- 229910001607 magnesium mineral Inorganic materials 0.000 claims 1
- 239000002245 particle Substances 0.000 claims 1
- 238000005516 engineering process Methods 0.000 abstract description 36
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 33
- 201000010099 disease Diseases 0.000 abstract description 32
- 230000006870 function Effects 0.000 abstract description 31
- 230000017531 blood circulation Effects 0.000 abstract description 28
- 208000001145 Metabolic Syndrome Diseases 0.000 abstract description 20
- 201000000690 abdominal obesity-metabolic syndrome Diseases 0.000 abstract description 19
- 238000001727 in vivo Methods 0.000 abstract description 13
- 230000032683 aging Effects 0.000 abstract description 12
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract description 9
- 239000008103 glucose Substances 0.000 abstract description 9
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract description 7
- 239000001301 oxygen Substances 0.000 abstract description 7
- 229910052760 oxygen Inorganic materials 0.000 abstract description 7
- 239000003925 fat Substances 0.000 abstract description 2
- 235000001497 healthy food Nutrition 0.000 abstract 2
- 229920001407 Modal (textile) Polymers 0.000 abstract 1
- 239000008188 pellet Substances 0.000 abstract 1
- 206010020772 Hypertension Diseases 0.000 description 65
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 45
- 230000036772 blood pressure Effects 0.000 description 42
- 235000015097 nutrients Nutrition 0.000 description 38
- 230000000694 effects Effects 0.000 description 37
- 230000001603 reducing effect Effects 0.000 description 32
- 235000000346 sugar Nutrition 0.000 description 32
- 208000008589 Obesity Diseases 0.000 description 31
- 235000020824 obesity Nutrition 0.000 description 31
- 235000019197 fats Nutrition 0.000 description 29
- 239000003814 drug Substances 0.000 description 26
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 25
- 230000001105 regulatory effect Effects 0.000 description 25
- 235000002639 sodium chloride Nutrition 0.000 description 25
- 210000004027 cell Anatomy 0.000 description 24
- 230000037213 diet Effects 0.000 description 23
- 230000002354 daily effect Effects 0.000 description 22
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 21
- 235000012000 cholesterol Nutrition 0.000 description 21
- 230000036541 health Effects 0.000 description 19
- 150000003839 salts Chemical class 0.000 description 17
- 159000000000 sodium salts Chemical class 0.000 description 17
- 230000001965 increasing effect Effects 0.000 description 16
- 206010003210 Arteriosclerosis Diseases 0.000 description 14
- 238000004458 analytical method Methods 0.000 description 14
- 208000011775 arteriosclerosis disease Diseases 0.000 description 14
- 102000004877 Insulin Human genes 0.000 description 13
- 108090001061 Insulin Proteins 0.000 description 13
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 13
- 210000004204 blood vessel Anatomy 0.000 description 13
- 206010012601 diabetes mellitus Diseases 0.000 description 13
- 229940125396 insulin Drugs 0.000 description 13
- 239000000126 substance Substances 0.000 description 13
- 230000001276 controlling effect Effects 0.000 description 12
- 230000001737 promoting effect Effects 0.000 description 12
- 230000002829 reductive effect Effects 0.000 description 12
- 230000000968 intestinal effect Effects 0.000 description 11
- 238000002360 preparation method Methods 0.000 description 11
- 208000024891 symptom Diseases 0.000 description 11
- 206010028980 Neoplasm Diseases 0.000 description 10
- 241000207961 Sesamum Species 0.000 description 10
- 238000010521 absorption reaction Methods 0.000 description 10
- 150000002632 lipids Chemical class 0.000 description 10
- 235000021049 nutrient content Nutrition 0.000 description 10
- 241000209140 Triticum Species 0.000 description 9
- 235000019634 flavors Nutrition 0.000 description 9
- 230000001976 improved effect Effects 0.000 description 9
- 238000005303 weighing Methods 0.000 description 9
- 206010010774 Constipation Diseases 0.000 description 8
- 239000002220 antihypertensive agent Substances 0.000 description 8
- 239000003963 antioxidant agent Substances 0.000 description 8
- 235000006708 antioxidants Nutrition 0.000 description 8
- 238000009472 formulation Methods 0.000 description 8
- 239000011780 sodium chloride Substances 0.000 description 8
- 108700012359 toxins Proteins 0.000 description 8
- 208000031226 Hyperlipidaemia Diseases 0.000 description 7
- 229940127088 antihypertensive drug Drugs 0.000 description 7
- -1 compound vitamin Chemical class 0.000 description 7
- 230000006378 damage Effects 0.000 description 7
- 230000002401 inhibitory effect Effects 0.000 description 7
- 150000003254 radicals Chemical class 0.000 description 7
- 230000009467 reduction Effects 0.000 description 7
- 235000015598 salt intake Nutrition 0.000 description 7
- 208000004930 Fatty Liver Diseases 0.000 description 6
- 206010019708 Hepatic steatosis Diseases 0.000 description 6
- 206010033307 Overweight Diseases 0.000 description 6
- 208000006011 Stroke Diseases 0.000 description 6
- 230000003078 antioxidant effect Effects 0.000 description 6
- 230000009286 beneficial effect Effects 0.000 description 6
- 230000037396 body weight Effects 0.000 description 6
- 208000010706 fatty liver disease Diseases 0.000 description 6
- 235000012631 food intake Nutrition 0.000 description 6
- 230000037406 food intake Effects 0.000 description 6
- 230000002503 metabolic effect Effects 0.000 description 6
- 230000003647 oxidation Effects 0.000 description 6
- 238000007254 oxidation reaction Methods 0.000 description 6
- 231100000240 steatosis hepatitis Toxicity 0.000 description 6
- 210000002700 urine Anatomy 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 208000017667 Chronic Disease Diseases 0.000 description 5
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 5
- 208000002720 Malnutrition Diseases 0.000 description 5
- 201000011510 cancer Diseases 0.000 description 5
- 235000005473 carotenes Nutrition 0.000 description 5
- 150000001746 carotenes Chemical class 0.000 description 5
- 235000013339 cereals Nutrition 0.000 description 5
- 208000029078 coronary artery disease Diseases 0.000 description 5
- 235000015872 dietary supplement Nutrition 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 230000030136 gastric emptying Effects 0.000 description 5
- 230000007661 gastrointestinal function Effects 0.000 description 5
- 229960003284 iron Drugs 0.000 description 5
- 238000012536 packaging technology Methods 0.000 description 5
- 230000028327 secretion Effects 0.000 description 5
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 5
- UUUHXMGGBIUAPW-UHFFFAOYSA-N 1-[1-[2-[[5-amino-2-[[1-[5-(diaminomethylideneamino)-2-[[1-[3-(1h-indol-3-yl)-2-[(5-oxopyrrolidine-2-carbonyl)amino]propanoyl]pyrrolidine-2-carbonyl]amino]pentanoyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoyl]amino]-3-methylpentanoyl]pyrrolidine-2-carbon Chemical compound C1CCC(C(=O)N2C(CCC2)C(O)=O)N1C(=O)C(C(C)CC)NC(=O)C(CCC(N)=O)NC(=O)C1CCCN1C(=O)C(CCCN=C(N)N)NC(=O)C1CCCN1C(=O)C(CC=1C2=CC=CC=C2NC=1)NC(=O)C1CCC(=O)N1 UUUHXMGGBIUAPW-UHFFFAOYSA-N 0.000 description 4
- 239000004375 Dextrin Substances 0.000 description 4
- 229920001353 Dextrin Polymers 0.000 description 4
- 208000008167 Magnesium Deficiency Diseases 0.000 description 4
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 4
- 229920000715 Mucilage Polymers 0.000 description 4
- 240000007594 Oryza sativa Species 0.000 description 4
- 235000007164 Oryza sativa Nutrition 0.000 description 4
- 102000004270 Peptidyl-Dipeptidase A Human genes 0.000 description 4
- 108090000882 Peptidyl-Dipeptidase A Proteins 0.000 description 4
- 244000197580 Poria cocos Species 0.000 description 4
- 229920002472 Starch Polymers 0.000 description 4
- 239000000853 adhesive Substances 0.000 description 4
- 235000019789 appetite Nutrition 0.000 description 4
- 230000036528 appetite Effects 0.000 description 4
- 210000004556 brain Anatomy 0.000 description 4
- 235000021152 breakfast Nutrition 0.000 description 4
- 239000003054 catalyst Substances 0.000 description 4
- 229940107218 chromium Drugs 0.000 description 4
- 238000000748 compression moulding Methods 0.000 description 4
- 230000000875 corresponding effect Effects 0.000 description 4
- 230000007547 defect Effects 0.000 description 4
- 230000006866 deterioration Effects 0.000 description 4
- 235000019425 dextrin Nutrition 0.000 description 4
- PVBRXXAAPNGWGE-LGVAUZIVSA-L disodium 5'-guanylate Chemical compound [Na+].[Na+].C1=2NC(N)=NC(=O)C=2N=CN1[C@@H]1O[C@H](COP([O-])([O-])=O)[C@@H](O)[C@H]1O PVBRXXAAPNGWGE-LGVAUZIVSA-L 0.000 description 4
- 235000006694 eating habits Nutrition 0.000 description 4
- 210000003734 kidney Anatomy 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 230000007774 longterm Effects 0.000 description 4
- 235000004764 magnesium deficiency Nutrition 0.000 description 4
- 230000004060 metabolic process Effects 0.000 description 4
- 210000005036 nerve Anatomy 0.000 description 4
- 235000009566 rice Nutrition 0.000 description 4
- 230000036186 satiety Effects 0.000 description 4
- 235000019627 satiety Nutrition 0.000 description 4
- 239000002002 slurry Substances 0.000 description 4
- 235000019698 starch Nutrition 0.000 description 4
- 239000008107 starch Substances 0.000 description 4
- 230000002889 sympathetic effect Effects 0.000 description 4
- 239000006188 syrup Substances 0.000 description 4
- 235000020357 syrup Nutrition 0.000 description 4
- 235000019640 taste Nutrition 0.000 description 4
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 4
- 235000013311 vegetables Nutrition 0.000 description 4
- LUEWUZLMQUOBSB-FSKGGBMCSA-N (2s,3s,4s,5s,6r)-2-[(2r,3s,4r,5r,6s)-6-[(2r,3s,4r,5s,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5s,6r)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical group O[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@@H](O[C@@H]2[C@H](O[C@@H](OC3[C@H](O[C@@H](O)[C@@H](O)[C@H]3O)CO)[C@@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O LUEWUZLMQUOBSB-FSKGGBMCSA-N 0.000 description 3
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 3
- 235000016068 Berberis vulgaris Nutrition 0.000 description 3
- 241000335053 Beta vulgaris Species 0.000 description 3
- 208000024172 Cardiovascular disease Diseases 0.000 description 3
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 description 3
- 206010012735 Diarrhoea Diseases 0.000 description 3
- 229920002581 Glucomannan Polymers 0.000 description 3
- 201000001431 Hyperuricemia Diseases 0.000 description 3
- 208000019025 Hypokalemia Diseases 0.000 description 3
- 208000017170 Lipid metabolism disease Diseases 0.000 description 3
- 208000001132 Osteoporosis Diseases 0.000 description 3
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 3
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 3
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 3
- 229940024606 amino acid Drugs 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 235000021120 animal protein Nutrition 0.000 description 3
- 230000003042 antagnostic effect Effects 0.000 description 3
- 230000003064 anti-oxidating effect Effects 0.000 description 3
- 239000008047 antioxidant nutrient Substances 0.000 description 3
- 230000036770 blood supply Effects 0.000 description 3
- 235000017471 coenzyme Q10 Nutrition 0.000 description 3
- 229940110767 coenzyme Q10 Drugs 0.000 description 3
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 description 3
- 230000034994 death Effects 0.000 description 3
- 231100000517 death Toxicity 0.000 description 3
- 238000005238 degreasing Methods 0.000 description 3
- 230000008021 deposition Effects 0.000 description 3
- 235000011869 dried fruits Nutrition 0.000 description 3
- 235000013399 edible fruits Nutrition 0.000 description 3
- 230000002708 enhancing effect Effects 0.000 description 3
- 230000003203 everyday effect Effects 0.000 description 3
- 229940046240 glucomannan Drugs 0.000 description 3
- 235000001727 glucose Nutrition 0.000 description 3
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 3
- 208000019622 heart disease Diseases 0.000 description 3
- 230000003914 insulin secretion Effects 0.000 description 3
- 210000000936 intestine Anatomy 0.000 description 3
- 235000000824 malnutrition Nutrition 0.000 description 3
- 230000001071 malnutrition Effects 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 230000003340 mental effect Effects 0.000 description 3
- 238000000465 moulding Methods 0.000 description 3
- 208000015380 nutritional deficiency disease Diseases 0.000 description 3
- 230000020477 pH reduction Effects 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 231100000572 poisoning Toxicity 0.000 description 3
- 230000000607 poisoning effect Effects 0.000 description 3
- 208000007645 potassium deficiency Diseases 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 235000021023 sodium intake Nutrition 0.000 description 3
- 230000000087 stabilizing effect Effects 0.000 description 3
- 230000035882 stress Effects 0.000 description 3
- 229940126680 traditional chinese medicines Drugs 0.000 description 3
- 235000019155 vitamin A Nutrition 0.000 description 3
- 239000011719 vitamin A Substances 0.000 description 3
- 229940045997 vitamin a Drugs 0.000 description 3
- 239000013585 weight reducing agent Substances 0.000 description 3
- 241000251468 Actinopterygii Species 0.000 description 2
- 208000019901 Anxiety disease Diseases 0.000 description 2
- 241001474374 Blennius Species 0.000 description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 2
- 244000000626 Daucus carota Species 0.000 description 2
- 235000002767 Daucus carota Nutrition 0.000 description 2
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical compound [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 2
- 206010013911 Dysgeusia Diseases 0.000 description 2
- 208000032928 Dyslipidaemia Diseases 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 2
- 244000303040 Glycyrrhiza glabra Species 0.000 description 2
- QAQJMLQRFWZOBN-LAUBAEHRSA-N L-ascorbyl-6-palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O QAQJMLQRFWZOBN-LAUBAEHRSA-N 0.000 description 2
- 239000011786 L-ascorbyl-6-palmitate Substances 0.000 description 2
- 102000007330 LDL Lipoproteins Human genes 0.000 description 2
- 108010007622 LDL Lipoproteins Proteins 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 108010053210 Phycocyanin Proteins 0.000 description 2
- 244000062793 Sorghum vulgare Species 0.000 description 2
- 229930187719 Soyasaponin Natural products 0.000 description 2
- 108010073771 Soybean Proteins Proteins 0.000 description 2
- 235000006092 Stevia rebaudiana Nutrition 0.000 description 2
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 2
- LNTHITQWFMADLM-UHFFFAOYSA-N anhydrous gallic acid Natural products OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 2
- 230000036506 anxiety Effects 0.000 description 2
- 235000021407 appetite control Nutrition 0.000 description 2
- 235000010385 ascorbyl palmitate Nutrition 0.000 description 2
- 210000004958 brain cell Anatomy 0.000 description 2
- 229960005069 calcium Drugs 0.000 description 2
- 229940069978 calcium supplement Drugs 0.000 description 2
- 235000019577 caloric intake Nutrition 0.000 description 2
- 229940077731 carbohydrate nutrients Drugs 0.000 description 2
- 208000026106 cerebrovascular disease Diseases 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 239000002934 diuretic Substances 0.000 description 2
- 230000001882 diuretic effect Effects 0.000 description 2
- 230000035622 drinking Effects 0.000 description 2
- 230000002526 effect on cardiovascular system Effects 0.000 description 2
- 230000037149 energy metabolism Effects 0.000 description 2
- 235000020774 essential nutrients Nutrition 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 235000019264 food flavour enhancer Nutrition 0.000 description 2
- 229940074391 gallic acid Drugs 0.000 description 2
- 235000004515 gallic acid Nutrition 0.000 description 2
- 229940095686 granule product Drugs 0.000 description 2
- 235000021192 high fiber diet Nutrition 0.000 description 2
- 210000005260 human cell Anatomy 0.000 description 2
- 235000003642 hunger Nutrition 0.000 description 2
- 201000001421 hyperglycemia Diseases 0.000 description 2
- 230000001631 hypertensive effect Effects 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000007786 learning performance Effects 0.000 description 2
- 235000011477 liquorice Nutrition 0.000 description 2
- 235000014659 low sodium diet Nutrition 0.000 description 2
- 238000003754 machining Methods 0.000 description 2
- 208000030159 metabolic disease Diseases 0.000 description 2
- 150000002772 monosaccharides Chemical class 0.000 description 2
- 210000000663 muscle cell Anatomy 0.000 description 2
- 235000021096 natural sweeteners Nutrition 0.000 description 2
- 235000018343 nutrient deficiency Nutrition 0.000 description 2
- 235000008935 nutritious Nutrition 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 230000036285 pathological change Effects 0.000 description 2
- 231100000915 pathological change Toxicity 0.000 description 2
- 230000036581 peripheral resistance Effects 0.000 description 2
- 210000002381 plasma Anatomy 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 230000002035 prolonged effect Effects 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 235000019608 salt taste sensations Nutrition 0.000 description 2
- 235000021148 salty food Nutrition 0.000 description 2
- 229940091258 selenium supplement Drugs 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 235000019710 soybean protein Nutrition 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 230000009885 systemic effect Effects 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 2
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 2
- 229940116269 uric acid Drugs 0.000 description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 description 2
- 239000008158 vegetable oil Substances 0.000 description 2
- 230000004580 weight loss Effects 0.000 description 2
- 230000002087 whitening effect Effects 0.000 description 2
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- SERLAGPUMNYUCK-DCUALPFSSA-N 1-O-alpha-D-glucopyranosyl-D-mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O SERLAGPUMNYUCK-DCUALPFSSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- LDCYZAJDBXYCGN-VIFPVBQESA-N 5-hydroxy-L-tryptophan Chemical compound C1=C(O)C=C2C(C[C@H](N)C(O)=O)=CNC2=C1 LDCYZAJDBXYCGN-VIFPVBQESA-N 0.000 description 1
- 229940000681 5-hydroxytryptophan Drugs 0.000 description 1
- 229940063062 5-hydroxytryptophan 200 mg Drugs 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 235000015579 Alternanthera sessilis Nutrition 0.000 description 1
- 240000002930 Alternanthera sessilis Species 0.000 description 1
- 206010002482 Angiosclerosis Diseases 0.000 description 1
- 235000017060 Arachis glabrata Nutrition 0.000 description 1
- 244000105624 Arachis hypogaea Species 0.000 description 1
- 235000010777 Arachis hypogaea Nutrition 0.000 description 1
- 235000018262 Arachis monticola Nutrition 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 235000007317 Avena nuda Nutrition 0.000 description 1
- 240000007054 Avena nuda Species 0.000 description 1
- 241000209763 Avena sativa Species 0.000 description 1
- 235000007558 Avena sp Nutrition 0.000 description 1
- 208000037157 Azotemia Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 1
- 239000005996 Blood meal Substances 0.000 description 1
- 240000004160 Capsicum annuum Species 0.000 description 1
- 235000008534 Capsicum annuum var annuum Nutrition 0.000 description 1
- 102000011632 Caseins Human genes 0.000 description 1
- 108010076119 Caseins Proteins 0.000 description 1
- 208000026889 Cell metabolism disease Diseases 0.000 description 1
- 206010008111 Cerebral haemorrhage Diseases 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- DQFBYFPFKXHELB-UHFFFAOYSA-N Chalcone Natural products C=1C=CC=CC=1C(=O)C=CC1=CC=CC=C1 DQFBYFPFKXHELB-UHFFFAOYSA-N 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 244000223760 Cinnamomum zeylanicum Species 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- 240000001980 Cucurbita pepo Species 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 241000238557 Decapoda Species 0.000 description 1
- 208000035240 Disease Resistance Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 241000628997 Flos Species 0.000 description 1
- FNUPUYFWZXZMIE-UHFFFAOYSA-N Fustin Natural products O1C2=CC(O)=CC=C2C(=O)C(O)C1C1=CC=C(O)C(O)=C1 FNUPUYFWZXZMIE-UHFFFAOYSA-N 0.000 description 1
- 241000222336 Ganoderma Species 0.000 description 1
- 208000018522 Gastrointestinal disease Diseases 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 239000004378 Glycyrrhizin Substances 0.000 description 1
- 241000251511 Holothuroidea Species 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- 235000007340 Hordeum vulgare Nutrition 0.000 description 1
- 208000006083 Hypokinesia Diseases 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- 206010022489 Insulin Resistance Diseases 0.000 description 1
- 229920001202 Inulin Polymers 0.000 description 1
- 244000017020 Ipomoea batatas Species 0.000 description 1
- 235000002678 Ipomoea batatas Nutrition 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 208000031662 Noncommunicable disease Diseases 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- 235000004347 Perilla Nutrition 0.000 description 1
- 244000124853 Perilla frutescens Species 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 240000004713 Pisum sativum Species 0.000 description 1
- 235000010582 Pisum sativum Nutrition 0.000 description 1
- 241000241413 Propolis Species 0.000 description 1
- 235000010580 Psophocarpus tetragonolobus Nutrition 0.000 description 1
- 244000046095 Psophocarpus tetragonolobus Species 0.000 description 1
- 206010038372 Renal arteriosclerosis Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 235000011684 Sorghum saccharatum Nutrition 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 206010043268 Tension Diseases 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 240000004922 Vigna radiata Species 0.000 description 1
- 235000010721 Vigna radiata var radiata Nutrition 0.000 description 1
- 235000011469 Vigna radiata var sublobata Nutrition 0.000 description 1
- 235000011453 Vigna umbellata Nutrition 0.000 description 1
- 240000001417 Vigna umbellata Species 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- 229920002522 Wood fibre Polymers 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 1
- 229960004373 acetylcholine Drugs 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- 230000003276 anti-hypertensive effect Effects 0.000 description 1
- 230000002180 anti-stress Effects 0.000 description 1
- 239000003472 antidiabetic agent Substances 0.000 description 1
- 239000003524 antilipemic agent Substances 0.000 description 1
- 230000004872 arterial blood pressure Effects 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 239000008122 artificial sweetener Substances 0.000 description 1
- 235000021311 artificial sweeteners Nutrition 0.000 description 1
- 235000013527 bean curd Nutrition 0.000 description 1
- 238000010009 beating Methods 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 1
- 235000005487 catechin Nutrition 0.000 description 1
- 150000003943 catecholamines Chemical class 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 235000005513 chalcones Nutrition 0.000 description 1
- 201000001883 cholelithiasis Diseases 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 229950001002 cianidanol Drugs 0.000 description 1
- 235000017803 cinnamon Nutrition 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- 238000002485 combustion reaction Methods 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 238000010411 cooking Methods 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 235000001434 dietary modification Nutrition 0.000 description 1
- 230000006806 disease prevention Effects 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 229910000397 disodium phosphate Inorganic materials 0.000 description 1
- 235000019800 disodium phosphate Nutrition 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 230000002996 emotional effect Effects 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 1
- 238000009207 exercise therapy Methods 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 239000004833 fish glue Substances 0.000 description 1
- 235000021323 fish oil Nutrition 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 239000005417 food ingredient Substances 0.000 description 1
- 235000019138 food restriction Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 description 1
- 229940107187 fructooligosaccharide Drugs 0.000 description 1
- 230000005714 functional activity Effects 0.000 description 1
- 238000010230 functional analysis Methods 0.000 description 1
- FNUPUYFWZXZMIE-HUUCEWRRSA-N fustin Chemical compound C1([C@@H]2[C@@H](C(C3=CC=C(O)C=C3O2)=O)O)=CC=C(O)C(O)=C1 FNUPUYFWZXZMIE-HUUCEWRRSA-N 0.000 description 1
- 208000001130 gallstones Diseases 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 230000004153 glucose metabolism Effects 0.000 description 1
- 208000018914 glucose metabolism disease Diseases 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- 239000008169 grapeseed oil Substances 0.000 description 1
- 238000009499 grossing Methods 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 230000037219 healthy weight Effects 0.000 description 1
- 229940126904 hypoglycaemic agent Drugs 0.000 description 1
- 230000007365 immunoregulation Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 1
- 229940029339 inulin Drugs 0.000 description 1
- 239000000905 isomalt Substances 0.000 description 1
- 235000010439 isomalt Nutrition 0.000 description 1
- HPIGCVXMBGOWTF-UHFFFAOYSA-N isomaltol Natural products CC(=O)C=1OC=CC=1O HPIGCVXMBGOWTF-UHFFFAOYSA-N 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 239000000832 lactitol Substances 0.000 description 1
- 235000010448 lactitol Nutrition 0.000 description 1
- VQHSOMBJVWLPSR-JVCRWLNRSA-N lactitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-JVCRWLNRSA-N 0.000 description 1
- 229960003451 lactitol Drugs 0.000 description 1
- 229960001518 levocarnitine Drugs 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 239000000944 linseed oil Substances 0.000 description 1
- 235000021388 linseed oil Nutrition 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 208000012866 low blood pressure Diseases 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 235000019713 millet Nutrition 0.000 description 1
- 235000021281 monounsaturated fatty acids Nutrition 0.000 description 1
- 208000001022 morbid obesity Diseases 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 230000001338 necrotic effect Effects 0.000 description 1
- 235000006180 nutrition needs Nutrition 0.000 description 1
- 235000003715 nutritional status Nutrition 0.000 description 1
- 235000019895 oat fiber Nutrition 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 239000004482 other powder Substances 0.000 description 1
- 230000004783 oxidative metabolism Effects 0.000 description 1
- LDCYZAJDBXYCGN-UHFFFAOYSA-N oxitriptan Natural products C1=C(O)C=C2C(CC(N)C(O)=O)=CNC2=C1 LDCYZAJDBXYCGN-UHFFFAOYSA-N 0.000 description 1
- NEGYEDYHPHMHGK-UHFFFAOYSA-N para-methoxyamphetamine Chemical compound COC1=CC=C(CC(C)N)C=C1 NEGYEDYHPHMHGK-UHFFFAOYSA-N 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 235000020232 peanut Nutrition 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 238000001050 pharmacotherapy Methods 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 230000037081 physical activity Effects 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000000291 postprandial effect Effects 0.000 description 1
- 235000013594 poultry meat Nutrition 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 238000004393 prognosis Methods 0.000 description 1
- 229940069949 propolis Drugs 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 235000005493 rutin Nutrition 0.000 description 1
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 1
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- 235000019643 salty taste Nutrition 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 235000017709 saponins Nutrition 0.000 description 1
- 150000004671 saturated fatty acids Chemical class 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- KQRXQIPRDKVZPW-ISZNXKAUSA-N sesaminol Chemical compound C1=C2OCOC2=CC([C@H]2OC[C@H]3[C@@H]2CO[C@@H]3C2=CC=3OCOC=3C=C2O)=C1 KQRXQIPRDKVZPW-ISZNXKAUSA-N 0.000 description 1
- KQRXQIPRDKVZPW-UHFFFAOYSA-N sesaminol Natural products C1=C2OCOC2=CC(C2OCC3C2COC3C2=CC=3OCOC=3C=C2O)=C1 KQRXQIPRDKVZPW-UHFFFAOYSA-N 0.000 description 1
- 230000036299 sexual function Effects 0.000 description 1
- 230000005586 smoking cessation Effects 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 150000003385 sodium Chemical class 0.000 description 1
- 229940080237 sodium caseinate Drugs 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 230000035488 systolic blood pressure Effects 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 235000021076 total caloric intake Nutrition 0.000 description 1
- 235000021139 traditional diet Nutrition 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- DCXXMTOCNZCJGO-UHFFFAOYSA-N tristearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 208000009852 uremia Diseases 0.000 description 1
- 230000006441 vascular event Effects 0.000 description 1
- 231100000216 vascular lesion Toxicity 0.000 description 1
- 230000002227 vasoactive effect Effects 0.000 description 1
- 239000003981 vehicle Substances 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 239000010497 wheat germ oil Substances 0.000 description 1
- 239000002025 wood fiber Substances 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
Landscapes
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention relates to a functional healthy food, in particular to an integral combined blood-cleaning and toxin-expelling food that integrates the functions of the comprehensive treatment since the source of the disease and the integral food treatment of metabolic syndrome as a whole, a processing method and an application thereof. The food consists of blood-cleaning polynosic food, blood-cleaning high-potassium salt, blood-cleaning multivitamin pellet and a quantitative combination package which is convenient for carrying and eating. The functional healthy food controls the exorbitant contents of glucose, fat and sodium slat in blood in vivo since the source of the disease to reduce three-high, restrain active oxygen, clean blood stasis, garbage and toxin, purify blood, promote blood circulation and ensure that organism cells metabolize normally. The invention also provides the technology for processing the blood-cleaning and toxin-expelling combined food which remedies the disease and keeps healthy, resists and prevents ageing and prolongs life.
Description
Technical Field
The invention relates to a functional health food, in particular to a blood-purifying and toxin-expelling integrated light-weight food for comprehensive treatment from a source of disease onset and integral dietary therapy metabolic syndrome, and a processing method and application thereof.
Background
1. Malnutrition leads to health crisis
With the development of society, the living standard of people is continuously improved, the infectious diseases which originally mainly harm the health of people are gradually reduced, the living standard is high and comfortable, people can obviously reduce fruits, vegetables and coarse grains after eating fine rice flour, meat oil and high sugar and salt for a long time in order to pursue the taste and the flavor, the intake of dietary fiber, vitamins and mineral nutrients which are necessary for the living health of people is seriously insufficient, so that the chronic non-infectious diseases related to nutrition, such as obesity, hypertension, hyperlipidemia, diabetes, coronary heart disease, cerebral apoplexy, fatty liver, cholelithiasis, malignant tumor and other modern 'rich diseases' are rapidly increased, and the problem becomes a prominent problem which influences the health of modern people.
2. Blood contamination and the root cause of all diseases
Blood is the root for life maintenance, and the normal circulation of blood in blood vessels is the basis of human health. Normally, clean blood flows around our body constantly, delivering nutrients, water and oxygen to 60 megacells, and carrying waste products from each cell to the lungs and kidneys, which are then expelled from the body via breath or urine.
If the nutrition ingested by the human body is unbalanced, the content of glucose, fat and salt in the blood in the human body is excessive, so that the blood is polluted, the normal blood balance state is broken, the blood viscosity is increased, the flow is not smooth, the blood supply of cells of the body is insufficient, the metabolic disturbance of the cells of the body occurs, the cells are aged and necrotic, various body unsuitable symptoms can be caused, and a plurality of diseases can be gradually produced by the human body.
For example, diabetes can occur when glucose content in blood in vivo is too high, which causes blood glucose fluctuation, insulin dysfunction (insulin resistance), and glucose metabolism disorder of body cells;
if the fat content in blood in vivo is excessive, the concentration of cholesterol and triglyceride in blood plasma is increased, and lipid metabolism disorder appears in body cells, systemic atherosclerosis can be accelerated, and hyperlipidemia can be caused;
if the content of sodium salt in blood in vivo is too high, the body has salt metabolism disorder, and the potassium deficiency can cause hypertension, thus causing damage and burden to the heart;
if the active oxygen in the blood in the body is excessive, excessive free radicals are generated in the body, the body is acidified and peroxidated, arteriosclerosis, diabetes and cancer are generated, the aging of the human body is accelerated, and even the human body is died prematurely;
if arteriosclerosis, coronary heart disease can occur due to insufficient blood supply;
if fat accumulates in the liver, … … fatty liver will be caused
Experts say that the occurrence of body cell metabolism disorder due to blood pollution, aging and blood stasis in vivo is the root cause of all diseases.
3. Medical defect
Clinically, hyperglycemia (diabetes), hypertension, dyslipidemia, obesity and the like are associated with each other and closely related, and various complications are often caused. Overweight can be converted into obesity, obesity can be converted into 'three-high', 'three-high' can be converted into 'three diseases', and 'three diseases' cause various complications, resulting in disability and death. In medicine, based on obesity, the body is malnutrition, and the metabolic disorders of body cells, including obesity, hyperglycemia, hypertension, hyperlipidemia, hyperuricemia, fatty liver and other modern rich diseases, are integrated in the same body to different degrees, called metabolic syndrome, and generate great harm to human health.
Currently, the treatment of metabolic syndrome is a global medical problem. Apparently, each risk factor of metabolic syndrome, such as obesity, diabetes, hypertension, hyperlipidemia, hyperuricemia, fatty liver and other chronic diseases related to nutrition, has different pathogenesis and pathological changes. However, it has been found that the causes of these chronic diseases are all from: the food is characterized by comprising the following raw materials, wherein the raw materials comprise a main raw material and a main raw material, wherein the main raw material comprises a main raw material and a main raw material, the main raw material comprises a main raw material, a main raw material and a supplementary raw material, the supplementary raw material comprises a main raw material and a supplementary raw material, and.
The traditional pharmacotherapy controls the chronic diseases not to start from the source of the diseases, but starts from the occurrence of 'body unsuitable symptoms', adopts simple 'blood sugar reduction', 'blood fat reduction' or 'blood pressure reduction' and the like, and local therapy of the medicine is used for reducing the 'high' or solving the 'symptoms'. As a result, the medicine cannot replace the nutrition, and cannot control the origin of the disease and the metabolic disturbance from the start of malnutrition ← → blood pollution, and only can improve symptoms, rebound after stopping taking medicine, treat the symptoms of 'no treatment of the root cause', and even take medicine for life in some cases.
4. Confusion of doctors
In clinical practice, the drug is difficult to treat metabolic syndromes such as obesity, diabetes, hypertension, hyperlipidemia, hyperuricemia, fatty liver and the like, the curative effect is limited, the duration is difficult, and the damage to the liver and kidney functions is often brought; when the hypoglycemic agent, the lipid-lowering agent and the uric acid-lowering agent are used, the high-time low fluctuation of indexes such as blood sugar, blood fat, uric acid and the like is large; it is understood that there are also an increasing number of overweight, obese and "three-high" people among medical personnel.
5. Prevention and treatment of metabolic syndrome, one of the most important tasks faced by modern medicine
At present, various measures are taken in various countries in the world to prevent and treat metabolic syndrome, but the incidence rate of the metabolic syndrome still shows a global increasing trend and seriously harms the health of modern people. How to prevent and treat 'three highs' and how to control metabolic syndrome has become one of the most important tasks facing the modern medical community.
Disclosure of Invention
The invention aims to provide a blood-purifying and toxin-expelling integrated food which controls the content of overhigh glucose, fat and sodium salt in blood in vivo from a source of disease occurrence, reduces 'three highs', inhibits active oxygen, cleans blood stasis garbage and toxin in vivo, purifies blood, promotes blood circulation, ensures normal metabolism of body cells, prevents diseases and body building without diseases, resists aging and prolongs life, and a processing method and an application technology thereof.
In order to achieve the purpose, the technical scheme of the invention is as follows:
a blood-purifying and toxin-expelling integrated food for comprehensive treatment from pathogenic sources and integral dietary therapy of metabolic syndrome consists of small blood-purifying and toxin-expelling units consisting of a blood-purifying and toxin-expelling integrated tablet rich in cellulose, a high potassium element content and multiple vitamin minerals and a quantitative combined package convenient to carry and eat.
The blood-cleaning and fiber-dredging nutritious supplementary meal is a nutritious supplementary meal designed and processed for controlling heat energy, controlling weight and preventing obesity.
The net blood circulation promoting high potassium salt is a high potassium nutrition seasoning salt designed and processed for controlling sodium salt, controlling blood pressure and stabilizing blood sugar;
the blood-purifying and blood-dredging multi-vitamin tablet is a nutritional supplement designed and processed for making up the nutritional deficiency of dinning diet, promoting metabolism, accelerating heat energy conversion and preventing body acidification and blood deterioration;
the quantitative combined package convenient to carry and eat is characterized in that the small nutrition units of the blood purifying and blood circulation promoting rich-fiber meal, the blood purifying and blood circulation promoting rich-potassium salt and the blood purifying and blood circulation promoting multi-dimensional tablet are respectively packaged into one quantitative small package for one meal, then the quantitative small package products of different units are mutually matched according to different symptoms and the nutrition regulation needs of different people, and the small quantitative combined package is packaged into the blood purifying and toxin expelling integrated food convenient to carry and eat again.
The blood-purifying and blood-dredging fiber-enriched meal processing technology is characterized in that according to the nutrition regulation requirements of metabolic syndrome crowds, required protein food raw materials, carbohydrate food raw materials and dietary fiber food raw materials are respectively processed into edible food blanks, and then functional grease, a nutrition enhancer and an excipient are added to be mixed, processed and pressed into cakes, tablets, granules, powder and other nutrition auxiliary meals with different shapes. In the formula of the daily eating amount of each person, the protein content accounts for 15-20% of the total calories; the fat content accounts for 20-30% of the total calorie; carbohydrates account for 55-65% of the total calories; the content of dietary fiber is 3-9 g; vitamin B1Vitamin B2Vitamin B6The contents of the chromium-containing trace elements are respectively 0.2-1.5 mg and 10-30 micrograms. Other vitamins and minerals are not supplemented according to the conventional standard recommended by the Chinese academy of nutrition. In the formula, high-protein, low-sugar and multi-vitamin nutrients contained in the nutrient composition enter the body and are continuously input into brain cells and muscle cells, the energy is continuous and energetic, the brain is kept clear, and the learning performance and the working efficiency are improved; the dietary fiber nutrient contained in the product can be fed into human body to produce satiety, control appetite, reduce food intake, inhibit gastric emptying time, delay intestinal sugar absorption, inhibit insulin secretion, stabilize blood sugar, reduce blood lipid, control body weight, and prevent obesity.
The blood-purifying and blood-dredging high-potassium salt processing technology is characterized in that according to the nutrition regulation requirements of metabolic syndrome crowds, a bitter-removing flavoring agent, mineral magnesium and dietary fiber food raw materials are added into potassium chloride to be mixed and processed into the nutrition seasoning salt with a salt taste or similar to the salt taste. In the formula of the daily eating amount of each person, the potassium: magnesium: the weight ratio of the dietary fiber is 3-6 g: 0-0.15 g: 3-9 g. In the formula, potassium chloride replaces sodium salt to control the content of the sodium salt in the diet to be overhigh, and the basically overhigh content of the sodium salt in cells in vivo is extruded out of the cells through the antagonistic action of potassium and is discharged out of the body along with urine, so that the blood pressure is reduced, the heart is protected, and the stroke is prevented; in the formula, 0.04-0.25% (wt) of liquiritin or liquiritigenin juice with corresponding amount is added into potassium chloride; or adding 0.02-0.125 wt% of sweet stevia or sweet stevia juice into potassium chloride; or adding artificial sweetener such as sodium cyclamate or acesulfame potassium 0.01-0.3 wt% or sweet juice to potassium chloride to eliminate bitter taste of potassium chloride; adding 0.5-3% (wt) of polyvalent organic acid such as malic acid, citric acid, tartaric acid or succinic acid into the mixture to eliminate the aftertaste of natural sweetener; the natural flavor enhancer such as sodium glutamate, sodium inosinate, sodium adenylate, etc. with 0.5-10% (wt) is added into the mixture to further improve the taste;
in the formula, the added mineral magnesium is as follows:
(1) reduced magnesium absorption to compensate for high fiber diets, preventing heart attack;
(2) in order to prevent serious magnesium deficiency often caused by frequent administration of diuretic for hypertension patients;
(3) in order to prevent potassium element from being separated from cells caused by magnesium deficiency;
(4) in order to reduce the cholesterol content in blood, keep blood vessels unblocked and help control hypertension;
in the formula, the dietary fiber is added as follows:
(1) dietary fiber can be used for inducing satiety, controlling appetite, reducing food intake, inhibiting gastric emptying time, delaying intestinal sugar absorption, controlling insulin secretion, stabilizing blood sugar, reducing blood lipid, and controlling body weight.
(2) Dietary fiber enters into body to regulate gastrointestinal function (regulate intestine), improve intestinal flora, relieve poisoning and diarrhea caused by harmful substances, prevent constipation, and discharge toxic substances in body.
The processing technology of the multidimensional tablet for cleaning blood and dredging blood is a tablet-shaped and granular nutritional supplement which is processed by combining according to a certain proportion through scientific calculation according to the nutritional regulation requirements of metabolic syndrome crowds and functional factors such as vitamins, mineral nutrients, metabolic catalysts, antioxidants and the like which are lacked in diet of daily life and urgently need to be supplemented, and the formula of the nutritional supplement consists of a reinforced formula and a basic formula. The fortified formula of the invention contains vitamin B in the daily consumption of each person1Vitamin B2Vitamin B6The content of the vitamin E is 1.5-30mg, the content of the vitamin C is 100-500mg, the content of the vitamin E is 10-300mg, the content of the mineral selenium is 25-50 mu g, and the content of the mineral chromium is 20-250 mu g. In the formula, the mineral chromium is added for enhancing the activity of insulin, regulating blood sugar and blood fat; adding vitamin B1Vitamin B2Vitamin B6Folic acid is to promote energy metabolism; adding vitamin B12Is to assist vitamin B2The active fat metabolism is played together, and the heat energy conversion is accelerated; folic acid is added to assist vitamin B2The deposition of fat on the artery wall is prevented, and high-risk vascular lesions are avoided; the vitamin C, the vitamin E and the mineral selenium are added to have a synergistic effect with carotene rich in the blood-purifying and fiber-enriching meal, so that the oxidation and sourness of the body and the blood deterioration are prevented, the cancer and disease prevention are realized, the aging is resisted, the life is prolonged.
The strengthening formula of the Jingxuetong multi-vitamin tablet aims to effectively prevent and treat diseases or maintain health, and increase the food therapy supply amount on the basis of the normal demand. The addition amount of nutrients such as vitamin B, vitamin C and vitamin E in the enriched formula is 2-3 times or more of the normal supply amount, which is most effective for maintaining health and diet therapy.
The basic formula is the formula with the daily edible amount of vitamin B for each person1Vitamin B2Vitamin B6The contents of the vitamin C, the vitamin E and the trace element chromium are respectively 1.2-1.5mg, 50-100mg, 10-60mg and 20-50 mug, and the contents of other vitamins and minerals are less than the supplement amount according to the conventional standard recommended by the Chinese society of nutrition. The patients with metabolic syndrome firstly carry out food therapy to regulate the organism nutrition through the blood-purifying and blood-circulation-promoting multi-vitamin tablet with the reinforced formula, and the blood-purifying and blood-circulation-promoting multi-vitamin tablet with the basic formula is used for maintaining food therapy health after the symptom improving poor nutritional status is relieved and the digestion is relieved.
The blood-purifying and blood-dredging multi-dimensional tablet is mainly explained by taking a reinforced formula, the basic formula is basically the same as the nutrition combination mode of the traditional compound vitamin mineral tablet, and the repeated explanation is not repeated below.
The invention relates to a quantitative combined packaging technology of a blood-purifying and toxin-expelling integrated light combined food, which is characterized in that each person takes a blood-purifying and toxin-expelling integrated food twice a day, and equally divides the blood-purifying and toxin-expelling integrated food into two parts, and the two parts are packaged into a small nutrition unit small packaging product which is convenient to carry and eat, so that the content of dietary fiber in the small nutrition unit small packaging product is (3-9)/2 g;
the high potassium salt for purifying blood and dredging blood for seasoning is divided into three parts with equal amount, and the three parts are packaged into a small nutrition unit small package product which is convenient to carry and eat, wherein the content of potassium element in the small nutrition unit small package product is (3-6)/3 g, and the content of dietary fiber in the small nutrition unit small package product is (3-9)/3 g;
the high-potassium salt powder product for purifying blood and dredging collaterals for seasoning for each person for three times a day is directly packaged into a quantitative bulk product with a measuring cup or a measuring spoon and an edible instruction for one cup or one spoon for one meal according to market demands, so that the dietary therapy supply amount of potassium element in the product is 3-6 g per person for each day, and the dietary therapy supply amount of dietary fiber is 3-17 g per person for each day;
the pure blood circulation-promoting dietary fiber-enriched meal which is eaten twice a day by each person is divided into two parts in equal amount, and each personThe Jingxuetong multivitamin tablets taken three times a day are divided into three parts in equal amount, and are respectively packaged into small packages of one meal, then two small nutrition units formed by five small packages are packaged into a combined packaging product (Jingxuetong richening meal and Jingxuetong multivitamin tablets) which is convenient to carry and eat one by one (bag or box) one day, and the two are combined to ensure that the vitamin B in the combined packaging product is vitamin B1Vitamin B2Vitamin B6The content of the chromium-containing trace element reaches 1.5-4.5 mg respectively, and the content of the trace element chromium reaches 20-250 micrograms.
The pure blood circulation-promoting and fiber-enriched meal which is eaten twice a day by each person is divided into two parts in equal amount, the pure blood circulation-promoting and high potassium salt which is seasoned and eaten three times a day by each person is divided into three parts in equal amount, the three parts are respectively packaged into small packages of one meal, and then two small nutrition units formed by five small packages are packaged into a combined packaging product which is convenient to carry and eat (the pure blood circulation-promoting and fiber-enriched meal and the pure blood circulation-promoting and high potassium salt) one day by one package (bag or box), and the two small nutrition units are combined to enable the content of dietary fiber in the combined packaging product to reach 8-17 g.
The invention divides the purified blood circulation-promoting fiber-enriched meal which is eaten twice a day by each person in equal amount into two parts, divides the purified blood circulation-promoting high-potassium salt which is eaten by seasoning three times a day by each person in equal amount into three parts, divides the purified blood circulation-promoting multi-dimensional tablet which is eaten by three times a day by each person in equal amount into three parts, respectively packages the three parts into small packages of one meal, and then packages the three small nutrition units formed by eight small packages into one bag (bag or box) for one day to carry the convenient (purified blood circulation-promoting fiber-enriched meal, purified blood circulation-promoting high-potassium salt and purified blood circulation-promoting multi-dimensional tablet) combined package product, wherein the three parts are combined, the content of the dietary fiber in the combined package reaches 8 to 17 grams, and the vitamin B1Vitamin B2Vitamin B6The content of the chromium-containing trace element reaches 1.5-4.5 mg respectively, and the content of the trace element chromium reaches 20-250 micrograms.
The protein food raw materials required by the processing of the blood-purifying and blood-dredging fiber-enriched small nutrition unit are various plant raw materials rich in protein nutrition and various low-cholesterol animal protein food raw materials, and the raw materials comprise soybean, spirulina, phycocyanin, wheat germ, soybean oligopeptide, cinnamon, small red bean, mung bean, pea, kidney bean, hyacinth bean, sesame, peanut, high-protein edible fungus, high-protein dried fruit, milk powder, chicken powder, fish powder, rabbit meat powder, gelatin, sodium caseinate, fish glue, dried sea cucumber, dried razor clam, high-protein dried fruit and other high-protein food raw materials, and one or more of the raw materials are selected and used in combination.
The carbohydrate food raw materials required by the processing of the blood-purifying and blood-dredging fiber-rich small nutrition unit are various grains, various dried fruits and various dried vegetable food raw materials rich in carbohydrate nutrients, and comprise corn, buckwheat, oat, wheat, barley, hulless oat, rice, millet, sorghum, sweet potato powder, yam powder, pumpkin powder, carrot powder, sweet pepper powder, seaweed powder, honey and various medicinal and edible dual-purpose food raw materials, and one or more of the raw materials are selected and used in combination.
The dietary fiber food raw materials required by processing the small blood circulation-purifying and fiber-enriched meal nutrition unit and the small blood circulation-purifying and high-potassium salt nutrition unit are various food raw materials rich in dietary fibers, and the raw materials comprise konjac flour, konjac powder, inulin, liquorice, poria cocos, corn fiber, soybean fiber, oat fiber, wheat fiber, carrot fiber, beet fiber, microcrystalline fiber, wood fiber, seaweed meal, various edible fungi, algae, oligosaccharide, water-soluble edible gum and the like rich in fibers, and one or more of the raw materials are selected and used in combination.
The functional grease required by the processing of the blood-purifying and blood-dredging fiber-enriched small nutrient unit is grease with the function of regulating blood fat, and the grease comprises corn germ oil, safflower oil, rice bran oil, wheat germ oil, perilla oil, linseed oil, grape seed oil, deep sea fish oil and various vegetable oils without cholesterol, including soybean oil, peanut oil, olive oil, sesame oil and the like, and is selected from one or more of the following components.
The nutrition enhancer required by the processing of the blood-purifying and blood-dredging integrated light combination food is functional nutrients such as various vitamins, mineral substances, metabolic catalysts, antioxidants and the like which are added according to the nutrition regulation requirements of metabolic syndrome crowds, and the raw materials of the nutrition enhancer comprise vitamin A and caroteneVitamin B1Vitamin B2Vitamin B6Vitamin C, vitamin D, vitamin E, folic acid, inositol, calcium, potassium, magnesium, iron, zinc, selenium, chromium, and methionine, lysine, taurine, tryptophan, L-carnitine, coenzyme Q10, fustin, ferment, phospholipid, propolis, safflower, maltitol, xylitol, sorbitol, isomalt, lactitol, D-mannitol, chitosan, etc., in combination.
The potassium chloride bitter-removing flavoring agent food raw materials required by the processing of the small blood circulation-cleaning high-potassium salt nutrition unit comprise liquorice, liquiritin, potassium glycyrrhetate, stevia rebaudiana, monosaccharide stevia rebaudiana, stevioside, malic acid, citric acid, tartaric acid, succinic acid, sodium glutamate, sodium inosinate, sodium guanylate, sodium adenylate, sodium phosphate, anhydrous calcium phosphate, artificially synthesized sodium cyclamate, acesulfame potassium and other sweeteners.
The edible food blank processed by the small blood circulation-cleaning and fiber-enriched meal nutrition unit is prepared by processing required protein food raw materials, carbohydrate food raw materials and dietary fiber food raw materials into clinker by adopting curing processes such as high-temperature frying or baking, puffing and the like before forming, cooling and crushing the raw materials, then adding nutrition enhancers such as vitamins, mineral substances and the like for compression forming, and performing ultrahigh-temperature instant sterilization and disinfection after forming and packaging to avoid secondary damage and loss of the nutrients such as the vitamins and the like in a high-temperature environment.
Detailed Description
The following will explain the implementation of the present invention in detail with reference to the following examples:
example one, blood-purifying and toxin-expelling integrated food processing technology (formula No. 1)
Technology for processing nutrient small unit of blood-purifying and blood-dredging fiber-enriched meal (No. 1 formula)
1. The formula (the amount of the food taken by each person is divided into two times per day): 4 g of spirulina, 10 g of defatted soybean, 6 g of konjac powder, 34.5 g of buckwheat, 4.5 g of corn germ oil, 1 g of L-carnitine, 0.171 mg of thiamine, 0.355 mg of riboflavin, 0.4 mg of pyridoxine, 30mg of ascorbic acid, 0.7 microgram of cholecalciferol, 4.82 mg of tocopherol, 21 microgram of folic acid, 30 microgram of chromium and 0.3 g of maltitol.
2. Analysis of nutrient content of small nutrition unit of Jingxuetong Fuweimeal (No. 1 formula)
TABLE-analysis table for nutrient components of nutrient small unit of blood-cleaning and blood-dredging Fuxue meal (No. 1 formula)
3. The blood-cleaning and blood-dredging fiber-enriched meal (formula No. 1) contains the functional components of the main raw materials of a small nutrition unit and the functions thereof.
(1) Spirulina: the main functional components of spirulina polysaccharide, spirulina phycocyanin, rich vitamins such as beta-carrot and the like and mineral nutrients have the functions of immunoregulation, blood fat regulation, fatigue resistance, tumor resistance and the like.
(2) Soybean: the main functional components are soybean protein, soyasaponin, soybean cellulose and other nutrients, wherein the soybean protein has the functions of regulating blood fat, reducing cholesterol and triglyceride, improving osteoporosis and inhibiting hypertension; the soyasaponin has effects in regulating blood sugar and blood lipid, preventing obesity, resisting thrombi, and resisting tumor; the soybean fiber has effects of improving gastrointestinal function (regulating intestine), regulating blood lipid, reducing cholesterol, and inhibiting blood sugar increase.
(3) Konjak flavor powder: the main functional component is glucomannan, and has multiple functions of losing weight, regulating blood sugar, regulating blood fat, improving constipation, improving intestinal flora and the like.
(4) Buckwheat: the main functional components are rutin, catechin and the like, and have the functions of regulating blood sugar, regulating blood fat, maintaining capillary vessels and preventing cerebral hemorrhage.
(5) L-carnitine: essential nutrients for human body, and has the functions of regulating blood fat, reducing weight, building body, resisting fatigue, delaying senility, etc.
(6) Corn germ oil: the functional oil contains various fatty acids as main effective components, does not contain cholesterol, and has the effects of regulating blood lipid and providing heat energy.
(7) Maltitol: the functional sweetener has effects of regulating blood sugar and reducing fat.
4. Technology for processing and forming small nutrition units of blood-purifying and blood-dredging Fuxian meal (No. 1 formula)
(1) Spirulina: selecting powder sold in the market;
(2) konjak flavor powder: selecting commercially available powder;
(3) l-carnitine, maltitol: selecting commercially available powder;
(4) defatted soybean: cleaning raw materials → drying → crushing → extruding and puffing with an extruder → drying and cooling → crushing → obtaining the puffed defatted soybean powder;
(5) buckwheat: processing defatted soybean to obtain puffed buckwheat flour;
(6) corn germ oil: heating at 150 deg.C, adding antioxidant such as ascorbic acid (liposoluble ascorbyl palmitate), tocopherol and 0.001-0.02 wt% gallic acid lactone, performing conventional oil antioxidant treatment, and adding into excipient preparation process;
(7) a nutrition enhancer: weighing thiamine, riboflavin, pyridoxine, folic acid, chromium and other nutrition enhancers according to the formula, and fully mixing; weighing cholecalciferol according to a formula, dissolving the cholecalciferol in a proper amount of ethanol, and then adding the ethanol solution into an excipient preparation procedure for mixing;
(8) excipients: adopts the conventional excipients commonly used in the production of traditional Chinese medicines, such as starch slurry, syrup, dextrin, mucilage, honey and the like, and one excipient is selected according to the production requirement.
(9) Powder mixing: weighing spirulina powder, defatted soybean puffed powder, buckwheat puffed powder, L-carnitine and maltitol according to a formula, premixing, adding fully premixed powdery nutrition enhancer, and mixing again; adding excipient containing ascorbic acid, tocopherol and cholecalciferol nutrients into the powdery mixture for mixing to make the raw materials in the formula mixed uniformly. The addition amount of the excipient is different from the molding requirement of the product, and the excipient can be adjusted by a production enterprise. For example, the powdery granule product is processed without the preparation process of an excipient and the compression molding process, and the edible food raw materials are directly and uniformly mixed after being subjected to anti-oxidation treatment.
(10) Molding: the prepared blank is processed into cake-shaped, sheet-shaped, granular or other-shaped products by a model or an extruder according to market requirements by adopting the traditional pressurizing production process.
(11) And (3) drying: the formed product is dried by hot air at 30-60 ℃, and the moisture content of the dried product is generally kept at about 3-13% (wt).
II, technology for processing high-potassium salt (A, B, C, D, E type formula) nutrition small unit for purifying blood
The A type formula blood-purifying high potassium salt processing technology comprises the following steps:
(1) the formula is as follows: 96.35 g of potassium chloride (with the potassium content of 47.55wt percent), 1.15 g of magnesium, 68.74 g of beet fiber (optional other dietary fiber), 1.0 g of sodium glutamate, 1.0 g of calcium phosphate, 1.0 g of malic acid, 0.1 g of sodium inosinate, 0.1 g of sodium guanylate and 0.15 g of liquiritin sodium.
(2) The preparation method comprises the following steps: heating potassium chloride, baking, parching, spraying Glycyrrhrizae radix sweetener (0.15 g Glycyrrhrizae radix sweetener dissolved in 5ml water) while stirring to adhere on potassium chloride granule surface, cooling, drying, adding other components, and stirring to obtain high potassium salt for cleaning blood.
(3) Reference consumption amount: the A type formula of the high potassium salt for cleaning blood circulation is taken by 14.8 g per person in three times per day, and the high potassium salt contains 4 g of potassium, 0.1 g of magnesium and 6 g of beet fiber.
The B-type formula blood-purifying and blood-dredging high potassium salt processing technology comprises the following steps:
(1) the formula is as follows: 70 g of potassium chloride (with the potassium content of 47.55wt percent), 0.83 g of magnesium, 50 g of corn fiber (which selects 80 percent of dietary fiber content and can also select other dietary fibers), 3.0 g of sodium glutamate, 1.0 g of calcium phosphate, 0.2 g of stevioside and 1.5 g of citric acid.
(2) The preparation method comprises the following steps: spraying stevioside in potassium chloride, and mixing with other components, as with the high potassium salt for cleaning blood.
(3) Reference consumption amount: the B type formula of the high potassium salt for cleaning blood circulation is taken by each person for three times by 15.2 g per day. It contains potassium 4 g, magnesium 0.1 g and corn fiber 6 g.
The processing technology of the C-type formulation high potassium salt for purifying blood circulation comprises the following steps:
(1) the formula is as follows: 96.2 g of potassium chloride (with the potassium content of 47.55wt percent), 1.14 g of magnesium, 68.7 g of microcrystalline fiber (other dietary fibers can be selected), 2 g of sodium glutamate, 1.0 g of calcium phosphate, 0.3 g of liquiritin disodium and 0.5 g of succinic acid.
(2) The preparation method comprises the following steps: spraying glycyrrhizin disodium onto potassium chloride, and mixing with other components.
(3) Reference consumption amount: the C-type net Xuetong high potassium salt is taken by 14.8 g three times per day. It contains potassium 4 g, magnesium 0.1 g and microcrystalline fibre 6 g.
Processing technology of D-type formulation high potassium salt for purifying blood
(1) The formula is as follows: 96.35 g of potassium chloride (with the potassium content of 47.55wt percent), 1.15 g of magnesium, 34.4 g of fructo-oligosaccharide (other dietary fibers can be selected), 10 g of citric acid powder, 9 g of sodium glutamate, 0.5 g of liquiritin, 5.5 g of sodium inosinate, 16 g of anhydrous sodium hydrogen phosphate powder and 5 g of sodium guanylate.
(2) The preparation method comprises the following steps: mixing the above materials thoroughly.
(3) Reference consumption amount: the D type formula of the high potassium salt for cleaning blood circulation is taken by each person in 15.5 g three times a day. It contains potassium 4 g, magnesium 0.1 g and oligofructose 3 g.
Processing technology of E-type formulation high potassium salt for purifying blood
(1) The formula is as follows: 90 g of potassium chloride (with the potassium content of 47.55 wt%), 1.07 g of magnesium, 64.3 g of apple fiber, 1 g of calcium phosphate, 1 g of sodium glutamate, 1 g of malic acid and 0.1 g of liquiritin.
(2) The preparation method comprises the following steps: dissolving liquiritin in 12 g of water, adding into parched potassium chloride, ventilating at 60 deg.C, drying, adding other components, and mixing. The blood circulation-cleaning high-potassium salt containing apple fiber has special sweetness, fragrance and sourness of apple, and is suitable for flavoring wheaten food.
(3) Reference consumption amount: the E type formula high potassium salt for cleaning blood circulation is taken by 14.8 g per person in three times per day, and contains 4 g of potassium, 0.1 g of magnesium and 6 g of apple fiber.
6. High-potassium salt (A, B, C, D, E type formula) nutrition small unit functional component for cleaning blood and dredging blood and function thereof
(1) Potassium chloride: the main functional component is potassium, and under normal conditions potassium in human cells and sodium outside the cells must be balanced with each other. If the human body takes excessive sodium and potassium in the body is not taken sufficiently, the sodium can bring a lot of water into cells, so that the originally insufficient potassium in the body can be extruded out and discharged out of the body along with urine to cause potassium deficiency in the body.
In recent years, many scholars have studied the relationship between potassium and blood pressure. As a result, potassium was found to be inversely related to blood pressure. Clinical observation shows that potassium chloride can regularly reduce blood pressure, and sodium chloride can increase blood pressure. More significantly, the pressure reduction effect per mm/l potassium is 3 times the pressure increase effect per mm/l sodium. Further studies have found that the higher the sodium intake, the more people who die from hypertension, and the earlier the onset of disease, among the ages.
In daily life, the human body needs quite a lot of potassium (adults need 2000-5500 mg of potassium per day). However, most people like salty food, and the eating amount of vegetables and fruits is small, so that the intake amount of potassium is generally low. The high-potassium salt for purifying blood replaces the traditional sodium chloride salt to season dinner diet, the potassium contained in the high-potassium salt can control the problem of overhigh sodium salt content in diet, and simultaneously, the originally overhigh sodium in cells in vivo is extruded out of the cells through the antagonistic action of the potassium and is discharged out of the body along with urine, so that the blood pressure is reduced, the heart is protected, and stroke is prevented;
(2) sweetening agent such as liquiritin, stevioside, monosaccharide stevia or corresponding amount of Sucus Glycyrrhizae and Sucus stevia can be added into potassium chloride to eliminate bitter taste of potassium chloride;
(3) the addition of polyvalent organic acids such as malic acid, citric acid, tartaric acid or succinic acid can improve the aftertaste of natural sweetener;
(4) the flavor enhancer such as sodium glutamate, sodium inosinate, sodium guanylate, and sodium adenine glycolate can be added to further improve taste;
(5) the added mineral magnesium is:
reducing the magnesium absorption amount in order to make up for high-fiber diet and preventing sudden heart disease;
② in order to prevent serious magnesium deficiency often existing when the hypertension patient often takes diuretic;
③ in order to prevent the potassium element from separating from the cell caused by magnesium deficiency;
fourthly, in order to reduce the cholesterol content in the blood, keep the blood vessel smooth and help to control the hypertension;
(6) the dietary fiber is added as follows:
firstly, dietary fiber enters into the body to generate satiety, control appetite, reduce food intake, inhibit gastric emptying time, delay the absorption of sugar in intestines, control the massive secretion of insulin, stabilize blood sugar, reduce blood fat and control weight;
② the dietary fiber enters into the body to regulate the gastrointestinal function (intestinal regulation), improve intestinal flora, alleviate poisoning and diarrhea caused by harmful substances, prevent constipation and discharge toxic substances in the body.
Description of the drawings: the present invention relates to a technology for processing a blood-purifying high-potassium salt (A, B, C, D, E type formula) nutrition small unit, which is improved on the basis of "a preparation method of non-sodium salt" on page 277 of Japanese patent publication No. Sho 63-38178, which is published by Chinese light industry Press and changes the selection of a new practical food processing technology ".
Technology for processing nutrition small unit of blood-purifying and blood-dredging multi-vitamin tablet (No. 1 intensified formula)
1. The formula (three times daily dose per person): thiamine 2.6 mg, riboflavin 3.9 mg, pyridoxine 2.6 mg, cyanocobalamin 6 mg, ascorbic acid 170 mg, cholecalciferol 4.3 mg, tocopherol 91 mg, folic acid 129 mg, calcium 359.7 mg, iron 2.2 mg, zinc 6.53 mg, selenium 28 mg, chromium 170 mg, inositol 13.2 mg.
2. Machining and forming
(1) Weighing powdery food raw materials such as thiamine, riboflavin, pyridoxine, ascorbic acid, folic acid, inositol, calcium, iron, zinc, selenium, chromium and the like according to the formula, and fully and uniformly mixing;
(2) weighing tocopherol and cholecalciferol in the formula, dissolving the tocopherol and the cholecalciferol in a proper amount of ethanol solvent respectively, mixing the tocopherol and the cholecalciferol, and adding the mixture into an excipient processing procedure for mixing;
(3) the excipient is the conventional excipient commonly used in traditional Chinese medicine production, such as starch slurry, syrup, dextrin, mucilage, honey and the like, and one excipient is selected according to production needs;
(4) adding excipient containing tocopherol and cholecalciferol nutrient components into the premixed powder, mixing, and then adopting the traditional pressurizing production process to press and prepare tablets or granulate and form. Drying the formed product by hot air at 30-60 ℃.
Four, blood-cleaning and body-smoothing integrated light (formula No. 1) combined food nutrition combination and function analysis
Table for analyzing nutrition combination and function of blood-purifying and toxin-expelling integrated light food (formula No. 1)
Five-purpose blood-purifying and toxin-expelling integrated light (formula No. 1) combined food quantitative combined packaging technology
According to different symptoms and the nutrition regulation needs of different people, the blood-purifying and toxin-expelling integrated light (formula No. 1) combined food can be packaged in a quantitative combination mode by adopting different units.
1.A small unit of nutrition quantitatively and individually packaged
A clean blood meal (formula No. 1) with fiber enriched, one small unit of nutrition, packaged individually: the purified blood circulation-promoting dietary fiber-enriched meal (formula No. 1) which is eaten twice a day by each person is divided into two parts in equal amount, and the two parts are packaged into a small package product which is convenient to carry and eat;
neat blood circulation high potassium salt (type C formula) one nutritional small unit dosed single package: the invention relates to a seasoning (C type formula) for cleaning blood and dredging high potassium salt, which is used for seasoning three times a day by each person, and is packaged into a small package product which is convenient to carry and eat by one meal;
neat blood circulation high potassium salt (type C formula) a nutritional small unit dosing bulk: the invention relates to a high-potassium salt powder product for cleaning blood and dredging collaterals, which is directly packaged into a quantitative bulk product with a measuring cup (or a measuring spoon) and an eating instruction for one meal and one cup (or spoon) according to market requirements.
2. Quantitative combined package for two small nutrition units
A purified blood circulation-promoting fiber-enriched meal (formula No. 1) and a purified blood circulation-promoting multi-vitamin tablet (formula No. 1) are packaged in a quantitative combination manner by two small nutrition units: the pure blood circulation-promoting dietary fiber-enriched meal (formula No. 1) which is eaten twice a day by each person is divided into two parts in equal amount; the Jingxuetong multi-vitamin tablet taken by each person three times a day is divided into three parts in equal amount, and the three parts are respectively packaged into small packages of one meal, and then two nutritional small units consisting of five small packages are packaged into a one-day (bag or box) combined packaging product which is convenient to carry and eat (Jingxuetong enriched meal + Jingxuetong multi-vitamin tablet).
A purified blood circulation-promoting fiber-enriched meal (formula No. 1) and a purified blood circulation-promoting high-potassium salt (formula type C) are packaged in a quantitative combination manner by two small nutrition units: the pure blood circulation-promoting dietary fiber-enriched meal (formula No. 1) which is eaten twice a day by each person is divided into two parts in equal amount; the high potassium salt (C type formula) for purifying blood and dredging blood for seasoning is divided into three parts each day; the five small nutrition units are packaged into one small package for one meal respectively, and then are packaged into one bag (bag or box) for one day to carry the convenient (net blood circulation promoting rich fiber meal + net blood circulation promoting high potassium salt) combined package product.
3. Quantitative combined package of three nutrition small units: the blood circulation clearing and blood circulation promoting rich-fiber meal (formula No. 1), the blood circulation clearing high-potassium salt (formula C), the blood circulation clearing multi-vitamin tablet (formula No. 1) and three small nutrition units are quantitatively combined and packaged.
The pure blood circulation-promoting dietary fiber-enriched meal (formula No. 1) which is eaten twice a day by each person is divided into two parts in equal amount; the high potassium salt (C type formula) for purifying blood and dredging blood for seasoning is divided into three parts each day; the Jingxuetong multi-vitamin tablet (formula No. 1) which is taken by three times a day is divided into three parts in equal amount, each part is respectively packaged in small packages, and then three nutrition small units formed by eight small packages are packaged into a one-day-one-pack (bag or box) combined packaging product which is convenient to carry and eat (Jingxuetong enriched meal, Jingxuetong high potassium salt and Jingxuetong multi-vitamin tablet).
Example two, blood-purifying and toxin-expelling integrated food processing technology (formula No. 2)
Technology for processing nutrient small unit of blood-purifying and blood-dredging fiber-enriched meal (No. 2 formula)
1. The formula (the amount of the food taken by each person is divided into two times per day): 6 g of degreased milk powder, 12 g of wheat germ, 4 g of konjak flavor powder, 30 g of pumpkin powder, 3.66 g of rice bran oil, 1.57 g of safflower oil, 0.3 g of maltitol, 0.15 mg of thiamine, 0.4 mg of pyridoxine, 28 mg of ascorbic acid, 0.7 microgram of cholecalciferol, 21 microgram of folic acid and 30 microgram of chromium.
2. Analysis of nutrient content of small nutrition unit of Jingxuetong Fuweimeal (No. 2 formula)
Nutrient content analysis table for "Tanshi Jingxuetong" fiber-enriched meal (No. 2 formula)
3. Blood-purifying and fiber-removing dietary food (No. 2 formula) containing main raw material functional components of small nutrition units and effects thereof
(1) And (3) degreasing milk powder: the high-quality animal protein food raw material is rich in all necessary amino acids required by human life health, and has multiple functions of calcium supplement, weight reduction, brain strengthening, aging resistance, sub-health state improvement and the like.
(2) Wheat germ: the high-quality protein nutrition enhancer is rich in protein and fatty acid required by human life health.
(3) Konjak flavor powder: the main functional component is glucomannan, and has multiple functions of losing weight, regulating blood sugar, regulating blood fat, improving constipation, improving intestinal flora and the like.
(4) Pumpkin powder: contains a large amount of pectin fiber, and can slow the absorption of saccharide and delay the gastric emptying time, so that the blood sugar is not too fast after meals; in addition, the cobalt contained in the pumpkin powder is an essential trace element synthesized by insulin cells, can promote the secretion of insulin and control the rise of blood sugar after meals; the chromium contained in the pumpkin powder is an auxiliary factor of insulin and is also a component of a glucose tolerance factor, and can improve the activity of insulin and improve glucose metabolism. In japan, pumpkin powder is considered as a specific drug for the prevention and treatment of diabetes.
(5) Mixing rice bran oil and safflower oil: the rice bran oil 70 wt% and safflower oil 30 wt% can be mixed for reducing cholesterol, and the dietotherapy effect can be improved by 1.4-1.8 times compared with that of the functional oil taken alone.
(6) Maltitol: functional sweetener has effects of regulating blood sugar and reducing fat.
4. Technology for processing and forming small nutrition unit of blood-purifying and blood-dredging Fuxian meal (No. 2 formula)
(1) And (3) degreasing milk powder: the commercial powder is directly used;
(2) konjak flavor powder: the commercial powder is directly used;
(3) pumpkin powder: puffing, pulverizing or directly using;
(4) maltitol: powder is selected and purchased for direct use;
(5) rice bran oil + safflower oil: mixing at a certain proportion, heating at 150 deg.C, adding antioxidant such as ascorbic acid (liposoluble ascorbyl palmitate is selected as ascorbic acid) and 0.001-0.02 wt% gallic acid lactone, and performing conventional antioxidant treatment.
(6) Wheat germ: after baking, when the water content is below 6 wt%, the rice bran safflower mixed oil which is subjected to oxidation resistance treatment is sprayed on the surface of the wheat germ grains and is uniformly coated, so that the problem of oxidation of oil contained in the wheat germ is prevented, and the retention period of the product is prolonged.
(7) A nutrition enhancer: weighing thiamine, riboflavin, pyridoxine, folic acid, chromium and other powder according to the formula, and fully mixing; dissolving cholecalciferol in proper amount of ethanol, and adding the ethanol solution as additive to the excipient.
(8) Excipients: adopts the conventional excipients commonly used in the production of traditional Chinese medicines, such as starch slurry, syrup, dextrin, mucilage, honey and the like, and one excipient is selected according to the production requirement.
(9) Powder mixing: weighing various edible powder materials according to a formula, mixing, adding the wheat germ grains subjected to the anti-oxidation treatment and the nutrition enhancer, fully mixing, adding the excipient containing the cholecalciferol, fully mixing and processing into wet powder, and uniformly mixing various raw materials in the formula. The addition amount of the excipient can be adjusted by manufacturers according to the molding requirements of different products.
(10) And (3) compression molding: the prepared blank is processed into cake-shaped, sheet-shaped, granular or other shaped products by a model and extrusion according to market requirements by adopting the traditional pressurizing production process. For example, the powdered granule product is processed without the preparation process of an excipient and the compression molding process, and the edible raw materials are directly and uniformly mixed after being subjected to anti-oxidation treatment.
(11) And (3) drying: the formed product is dried by hot air at 30-60 ℃, and the moisture content of the dried product is generally kept at about 3-13% (wt).
Second, clean blood circulation high potassium salt (B type formula) nutrition small unit processing technology
See example a B formulation for the processing of neat xuetong high potassium salt and related description.
Technology for processing nutrition small unit of blood-purifying and blood-dredging multi-vitamin tablet (No. 2 intensified formula)
1. The formula (three times daily dose per person): thiamine 3.9 mg, riboflavin 2.6 mg, pyridoxine 2.6 mg, cyanocobalamin 6 mg, ascorbic acid 170 mg, cholecalciferol 4.3 mg, tocopherol 89.24 mg, folic acid 129 mg, calcium 259 mg, zinc 4.71 mg, selenium 27.5 mg, chromium 170 mg.
2. And (3) processing and forming:
(1) weighing powdery food raw materials such as thiamine, riboflavin, pyridoxine, ascorbic acid, folic acid, calcium, zinc, selenium, chromium and the like according to the formula, and fully and uniformly mixing.
(2) Weighing tocopherol and cholecalciferol in the formula, respectively dissolving in a proper amount of ethanol solvent, mixing the tocopherol and the cholecalciferol, and then adding the mixed ethanol solution into the excipient preparation process for mixing.
(3) The excipient is conventional excipient commonly used in traditional Chinese medicine production, such as starch slurry, syrup, dextrin, mucilage, honey, etc., and one or more excipients are selected and used together according to production needs.
(4) Adding an excipient containing tocopherol and cholecalciferol nutrient components into the premixed powder, mixing and blending the powder, and then adopting the traditional pressurizing and production process to press a die to prepare a tablet or granulate and form the tablet. Drying the formed product by hot air at 30-60 ℃.
Nutrient combination and function analysis of blood-purifying and toxin-expelling body-lightening (formula No. 2) combined food
Nutrient component and function analysis table of blood-purifying and toxin-expelling integrated light (formula No. 2) combined food
Fifth, the quantitative combined packaging technology of blood-purifying and toxin-expelling integrated light (formula 2) combined food is the same as the first embodiment, and the description of the first embodiment is referred to.
Example three, blood-purifying and toxin-expelling integrated food processing technology (formula No. 3)
Technology for processing nutrient small unit of blood-purifying and blood-dredging fiber-enriched meal (No. 3 formula)
1. The formula (the amount of the food taken by each person is divided into two times per day): 2.0 g of soybean oligopeptide, 9 g of sesame, 6 g of konjac powder, 41 g of oat, 0.8 g of safflower, 300mg of taurine, 0.25 mg of thiamine, 0.32 mg of riboflavin, 0.4 mg of pyridoxine, 30mg of ascorbic acid, 1 microgram of cholecalciferol, 4.34 mg of tocopherol, 21 microgram of folic acid and 30 microgram of chromium. In the formula, the carotene contained in the safflower can also be replaced by natural carotene or vitamin A with corresponding amount and added into the processing of the blood-purifying and blood-dredging multivitamin tablet (formula No. 3).
2. Analysis of nutrient content of small nutrition unit of Jingxuetong Fuweimeal (No. 3 formula)
Table five table for analyzing nutrient content of blood circulation-cleaning and fiber-enriching meal (formula No. 3)
3. Blood-purifying and fiber-removing dietary food (No. 3 formula) containing main raw material functional components of small nutrition units and effects thereof
(1) Soybean oligopeptide: the substances for regulating blood pressure are rich in protein and amino acid necessary for human body, and have the functions of reducing blood pressure, reducing blood fat, regulating blood sugar, regulating gastrointestinal function, eliminating free radicals, delaying senility and the like.
(2) Sesame: contains a large amount of antioxidant substances, and is a nutritional treasure house for resisting oxidation and acid of human body. Wherein the sesaminol and the sesame contain rich unsaturated fatty acid, which can reduce the content of malignant cholesterol, prevent arteriosclerosis, prevent cancer and resist aging.
(3) Konjak flavor powder: the main functional component is glucomannan, and has multiple functions of losing weight, regulating blood sugar, regulating blood fat, improving constipation, improving intestinal flora and the like.
(4) Oat: it is rich in linoleic acid and saponins, and can be used for reducing serum total cholesterol, triacylglycerol and beta-lipoprotein, and preventing and treating coronary heart disease, arteriosclerosis, diabetes, etc.
(5) Safflower: contains chalcone glycoside such as yellow A, B, C, is active component of Carthami flos, and has effects of reducing blood lipid, ascorbic acid, and improving oxygen resistance.
(6) Taurine: contains sulfur for inhibiting sympathetic nervous tension, and has effects in inhibiting stress, relieving fatigue, lowering blood pressure, reducing cholesterol content, protecting cardiac muscle, and enhancing cardiac activity.
4. Technology for processing and forming small nutrition unit of blood-purifying and blood-dredging Fuxian meal (No. 3 formula)
(1) Soybean oligopeptide: edible powder, used directly;
(2) konjak flavor powder: edible powder, used directly;
(3) oat: crushing → puffing → cooling and crushing → obtaining coarse oat puffed powder (or directly crushing after baking);
(4) sesame: baking and frying, adding the rough oat puffed powder according to the formula proportion, mixing the rough oat puffed powder and the rough oat puffed powder, and crushing the rough oat puffed powder and the rough oat puffed powder to obtain the refined sesame oat powder. Sesame has a large oil content, and if the fried sesame is directly pulverized, oil can seep out. The sesame powder is bonded and can not be uniformly dispersed. The fried sesame and the oat puffed powder are put together and crushed according to the formula weight ratio (9: 41), so that the oat powder can adsorb oil seeped from the sesame, and loose sesame and oat powder can be obtained;
(5) safflower: drying and crushing;
(6) excipients: the common traditional excipient is produced by adopting traditional Chinese medicines, and the details refer to the first embodiment and the second embodiment;
(7) powder mixing: the method refers to the first and second embodiments;
(8) and (3) compression molding: the method refers to the first and second embodiments;
(9) and (3) drying: the method is as described in examples one and two.
Second, clean blood circulation-promoting potassium-rich salt (A type formula) nutrition small unit processing technology
See example one. A type A formula high potassium salt processing technology for cleaning blood and dredging blood and related instructions.
Technology for processing three-dimensional blood-purifying and blood-dredging multi-vitamin tablet (No. 3 intensified formula) small nutrition unit
1. The formula (three doses per person per day): thiamine 2.6 mg, riboflavin 4.1 mg, pyridoxine 2.6 mg, cyanocobalamine 6 mg, ascorbic acid 170 mg, cholecalciferol 4 mg, developmental phenol 91 mg, folic acid 129 mg, calcium 263 mg, iron 1.6 mg, zinc 4.4 mg, selenium 27 mg, chromium 170 mg, coenzyme Q10: 50 mg.
2. Machining and forming
Reference is made to the description of the first and second embodiments
Nutrient component and function analysis of whitening, toxin expelling and body lightening (formula No. 3) combined food
Nutrient component and function analysis table of table six blood-purifying toxin-expelling body-lightening (formula No. 3) combined food
Fifthly, the quantitative combined packaging technology of the whitening and toxin expelling integrated light (formula No. 3) combined food is the same as the first embodiment. See the description of the first embodiment.
Example four, blood-purifying and toxin-expelling integrated food processing technology (formula No. 4)
Technology for processing nutrient small unit of blood-purifying and blood-dredging Fuxian meal (No. 4 formula)
1. The formula (the amount is eaten twice per day) comprises 23 g of defatted milk powder, 21 g of honey, 9 g of tuckahoe, 0.8 g of safflower, 5.5 g of sesame oil (which can be replaced by glossy ganoderma functional grease), 0.5 mg of thiamine, 0.17 mg of riboflavin, 0.6 mg of pyridoxine, 25 mg of ascorbic acid, 3.75 mg of cholecalciferol, 5.23 mg of tocopherol, 20 mg of folic acid, 1.05 mg of zinc, 5.8 mg of selenium, 26 mg of chromium and 1000.mg of L-carnitine. In the formula, the carotene contained in the safflower can also be replaced by natural carotene or vitamin A with corresponding amount and added into the processing of the blood-purifying and blood-dredging multivitamin tablet (formula No. 4).
2. Analysis of nutrient content of nutrition small unit of Jingxuetong Fuweimeal (No. 4 formula)
Nutrient content analysis table for "Taoqi" blood circulation-cleaning and fiber-enriching meal (No. 4 formula)
3. Blood circulation-cleaning and fiber-enriching meal (No. 4 formula) small nutrition unit main raw material functional component and effect thereof
(1) And (3) degreasing milk powder: the high-quality animal protein food raw material is rich in all necessary amino acids required by human life health, and has multiple functions of calcium supplement, weight reduction, brain strengthening, body building, aging resistance and sub-health state improvement.
(2) Honey: the honey contains sugar as main component, and also contains various functional components such as various enzymes, vitamins, minerals, flavonoids, acetylcholine, bacteriostat and the like, and has multiple functions of resisting bacteria, resisting oxidation and aging, promoting growth and development, beautifying, promoting tissue cell regeneration, resisting ulcer, relaxing bowels, reducing blood pressure, strengthening heart, reducing blood fat, resisting fatigue, protecting liver, resisting tumor, hypnotizing and the like.
(3) Tuckahoe, poria cocos: the main ingredient is pachyman, and has effects of regulating immunity, resisting tumor, resisting aging, tranquilizing, promoting urination, strengthening body constitution, etc.
(4) Sesame oil: is rich in unsaturated fatty acids such as oleic acid, linoleic acid, linolenic acid, etc., and can reduce cholesterol content.
(5) L-carnitine: essential nutrients for human body, and has the functions of regulating blood fat, reducing weight, building body, resisting fatigue, delaying senility, etc.
4. Technology for processing and forming small nutrition units of Jingxuetong Fuxian meal (No. 4 intensified formula)
Refer to the description of the first, second and third embodiments.
Second, clean blood circulation high potassium salt (B type formula) nutrition small unit processing technology
See example one (type B formulation) for the processing of high potassium salt for blood purification and related description.
Three, Jingxuetong multi-vitamin tablet (No. 4 formula) nutrition small unit processing technology
1. The formula (three times daily dose per person): thiamine 3.92 mg, riboflavin 4.06 mg, pyridoxine 3.9 mg, cyanocobalamin 6 mg, ascorbic acid 170 mg, cholecalciferol 1.25 mg, tocopherol 91 mg, folic acid 130 mg, calcium 95 mg, iron 4.68 mg, zinc 4.6 mg, selenium 43.3 mg, chromium 174 mg, pheochromosin 2 mg, 5-hydroxytryptophan 200 mg. The brown-black hormone and the 5-hydroxytryptophan in the formula are independently added in the processing of tablets or granules which are taken after dinner.
2. And (3) processing and forming:
refer to the description of the first and second embodiments.
Four, blood-purifying and toxin-expelling body-lightening (formula No. 4) combined food ingredient and function analysis
Table eight table for analyzing nutrient content and function of blood-purifying toxin-expelling body-light (formula No. 4) combined food
Five-component blood-purifying and toxin-expelling integrated light (formula No. 4) combined food quantitative combined packaging technology
See the description of the first embodiment for the same reference as the first embodiment.
Example five, blood-purifying and toxin-expelling integrated food processing technology (formula No. 5)
Technology for processing nutrient small unit of blood-purifying and blood-dredging fiber-enriched meal (No. 5 formula)
1. The formula (the amount of the food taken by each person is divided into two times per day): 13 g of black beans, 36 g of black rice (or 24 g of black rice and 12 g of polygonum multiflorum), 6 g of black sesame, 3 g of laver, 4.7 g of konjac powder, 0.8 g of safflower, 0.21 mg of thiamine, 0.262 mg of riboflavin, 0.4 mg of pyridoxine, 25 mg of ascorbic acid, 1.1 microgram of cholecalciferol, 21 microgram of folic acid and 30 microgram of chromium.
2. Analysis of nutrient content of small nutrition unit of Jingxuetong Fuweimeal (No. 5 formula)
Table for analyzing nutrient content of nutrient small unit in table nine-component blood-purifying and fiber-enriching meal (No. 5 formula)
3. Functional analysis of black food for Jingxuetong Fuxianfei meal (No. 5 formula)
(1) The melanin contained in the black food can inhibit glucose absorption, and has weight reducing effect;
(2) black color enters kidney, which is the source of life and is the material basis for various functional activities of human body. The black food has effects of invigorating kidney, enhancing immunity, promoting blood circulation, improving eyesight, and delaying aging;
(3) the melanin has the special functions of clearing free radicals in vivo, resisting oxidation, reducing blood fat, resisting tumor, beautifying and protecting skin, warming and nourishing the five internal organs and the like;
(4) konjak flavor powder: has effects in reducing weight, regulating blood sugar and blood lipid, relieving constipation, and improving intestinal flora.
(5) Polygonum multiflorum: has effects in nourishing liver and kidney, replenishing essence, blackening hair and beard, reducing cholesterol, triglyceride and beta-lipoprotein content, reducing arteriosclerosis, and preventing cardiovascular diseases.
4. Technology for processing and forming small nutrition units of blood-purifying and blood-dredging Fuxian meal (No. 5 formula)
The description is made with reference to the first, second, third and fourth embodiments.
Second, the following combined food processing techniques of the Jingxuetong high potassium salt (formulation No. 5) and the Jingxuetong multivitamin tablet (formulation No. 5) which are matched with the Jingxuetong Fuxianwei meal (formulation No. 5) can refer to the explanations and processing techniques of the first, second, third and fourth examples.
Application and function of blood-cleaning toxin-expelling light-weight combined food in food therapy
(for example, metabolic syndrome therapy involving hypertension and complications)
First, characteristics of hypertension
1. Disease without prognosis of hypertension
Many diseases are often preceded by various signs that indicate poor condition in the body, and therefore preventive measures can be taken to mitigate the harm to the body before the disease becomes more severe. However, hypertension, one of the hallmarks of modern civilized disease, is often referred to by humans as "predictive" disease. Therefore, many patients pay little attention to the medicine, and only take the antihypertensive medicine, even some people take the medicine only when feeling uncomfortable (accompanied with other complications), the consequences caused by hypertension always wait until obvious damage is caused to the body, and the people are discovered after suffering from various complications in vivo, and the time is often too late.
2. Complications of hypertension
The continuous rise of arterial pressure of hypertension patients causes systemic arteriosclerotic, thereby affecting the blood supply of tissues and organs, causing various serious consequences and becoming the complication of hypertension. Hypertension patients often have hyperlipidemia and diabetes, hypertension and renal arteriosclerosis and uremia, hypertension and heart disease, hypertension and coronary heart disease, hypertension and cerebrovascular accidents, which are important risk factors of cardiovascular and cerebrovascular diseases and participate in the occurrence of vascular events and pathological changes.
3. Low control rate of hypertension
Hypertension is the first disease of cardiovascular and cerebrovascular diseases, and has the characteristics of high incidence rate and low control rate. Each year, about 1200 or more million people die worldwide from hypertensive patients. About 1.1 hundred million people counted in 1999, wherein the age of 50 years or more accounts for 3/4, and the number of deaths is 200 million per year, which is the first of deaths from various diseases. At present, about 1.6 hundred million hypertension patients in China have a tendency of rising year by year.
Second, there are three major problems in preventing and treating hypertension in modern medicine
1. For preventing and treating hypertension, the obesity problem needs to be controlled firstly:
modern medical research shows that obesity is a main pathogenic factor of hypertension, the total blood dissolution of obese people is increased, the output of heart is increased, and the increase of blood volume discharged into blood vessels per minute is easy to cause hypertension;
the obese people frequently eat more food, the insulin level in the blood is higher than that of normal people, the sympathetic nerve function is easy to be stimulated, the blood vessel is contracted, the peripheral resistance of the blood vessel is increased, and the blood pressure is increased;
patients with obesity and hypertension are also prone to be complicated with dyslipidemia and diabetes, and the risk of arteriosclerosis is increased, resulting in further increase of blood pressure.
Experts say that 80% of hypertension patients can reduce blood pressure, heart rate, uric acid, cholesterol and blood sugar in blood plasma and reduce the dosage of medicine by losing weight. Therefore, how to control the body weight and reduce the obesity is the first problem of preventing and treating the hypertension of modern people.
Under the eye, obesity has become the most prevalent chronic disease in modern society. The current methods for preventing and treating obesity include drug therapy, exercise therapy, diet therapy, and the like, of which diet therapy is most important. The most basic diet therapy popular in the market at present is diet weight loss, however, the traditional diet weight loss is difficult for general people to insist on due to reduction of excessive hunger; the long-time food restriction can also reduce the intake of nutrients, so that the originally insufficient vitamins, minerals and dietary fiber nutrients in the body of an obese person are more deficient, the body cells generate metabolic disturbance, the physical strength is reduced, the exercise amount is reduced, the intelligence is reduced, the side effects of gallstone, hair falling, osteoporosis, sexual function reduction, hypodynamia, dizziness, worry and the like can be induced for a long time, most people can give up diet in the future, and the actual weight reduction is successful.
2. For preventing and treating hypertension, the problem of excessive sodium salt intake must be controlled:
common salt (sodium chloride) is the most basic seasoning, and almost all foods are seasoned with common salt or a salt-containing seasoning. In general, the physiological requirement of the human body for salt (sodium) does not exceed 3 g per day. The world health organization recommends that normal persons should not take more than 6 grams of salt, not more than 3 grams of hypertension patients and not more than 2 grams of diabetes patients. Unfortunately, however, most enjoy salty foods with a heavy taste and a daily salt intake that far exceeds the body's needs. According to statistics, Chinese residents all take 10-15 g of salt daily.
In recent years, it has been recognized that excessive salt intake is closely related to hypertension, heart disease, and kidney disease. International epidemiological studies have shown that the higher the sodium intake, the higher the blood pressure level, and the higher the number of people who die from hypertension, the earlier the disease occurs in people of all ages.
Clinical practice proves that the blood pressure of early-stage or light-stage hypertension patients can be recovered to be normal by only limiting salt. The salt intake of the patients with moderate and severe hypertension is limited, so that the curative effect of the antihypertensive drug can be improved, and the drug dosage can be reduced, thereby greatly reducing the side effect and the drug cost of the antihypertensive drug. Therefore, how to reduce the intake of sodium salt is a problem to be solved urgently for preventing and treating hypertension of modern people.
3. For preventing and treating hypertension, the body nutrition needs to be adjusted:
more than 40 nutrients needed for the health of human life are needed, theoretically, if the diet of people can achieve comprehensive, balanced and moderate effects, the nutrients such as vitamins, minerals and the like do not need to be supplemented by other methods. However, the actual situation is not so ideal, and many nutrients (at least 10 kinds) are hardly sufficiently obtained by ordinary foods. The method is characterized in that in the processes of modern chemical planting, food fine processing, food cooking and heating and food storage, nutrients such as vitamins and minerals contained in food are greatly lost and damaged, so that the necessary nutrients ingested by human bodies are less and less; in addition, the toxins entering the body and the free radicals generated in the body are increased due to environmental pollution, poor dietary habits, monophagia, dyspepsia and the like, and the intake of dietary fibers, vitamins, minerals and other nutrients required by the life health of human bodies is further lacked.
Under normal conditions, the nutrient components in the blood of a human body are generally balanced, if the nutrition ingested by the human body is unbalanced, the contents of glucose, fat and salt in the blood of the human body are excessive, and excessive free radicals are generated in the body, and the metabolic catalysts of the substances, such as vitamins and minerals, are excessively absorbed, the balance state of normal blood is broken, so that the excessive substances are converted into extravasated blood garbage and toxin, the blood is polluted, the viscosity of the blood is increased, the total dissolved amount of the blood is increased, and the flow is not smooth; in addition, the obese people often eat too much food and secrete too much insulin, which easily stimulates sympathetic nerve function, contracts blood vessels, increases peripheral resistance of the blood vessels and causes the rise of blood pressure.
Therefore, how to adjust the nutrition of the body is another problem which needs to be solved urgently by modern people for preventing and treating hypertension.
Thirdly, the blood-purifying and toxin-expelling dietotherapy effectively solves three major problems of hypertension prevention and treatment of modern people
1. The problem of healthy weight loss of obese people is effectively solved by using blood-purifying and fiber-dredging rich meal as supplementary meal
The traditional dietary habit of Chinese people is three meals a day, the interval between two meals is too long, especially the interval between lunch and dinner is usually 5-6 hours (which is generally the work requirement for office workers), and for overweight and obese people, the dietary habit is not beneficial to losing weight.
According to modern science, the general mixture fed by a human body stays in the stomach for about 4 hours, and the food in the stomach is emptied; in addition, most modern people eat the fine rice flour, the content of dietary fiber in food is low, the food can be quickly absorbed after eating, the blood sugar is quickly increased, and a large amount of secretion of insulin is stimulated to cause blood sugar fluctuation; when the time between two meals is too long, the human body can cause excessive hunger sensation and greatly increase the appetite, the general people can not control the appetite of the human body, and inevitably eat too much and drink too much, and the excessive food intake is very easy to be excessive for one time, so that the excessive food intake is accumulated for a long time; and mental labor replaces physical labor, vehicles replace walking, and physical activity is reduced, so that the fat content of the body is continuously increased until obesity is formed.
The dietician jenkins said that the french men were physically slim because they had meals at least 4 times a day, while northern europe had only 3 meals a day: sufficient breakfast, lunch and dinner at 6 pm, so they were obese.
The blood-cleaning and fiber-dredging rich meal (formula No. 3) is a diet and multi-meal which is carried out as an auxiliary meal, and high-protein, low-sugar and multi-vitamin nutrients contained in the blood-cleaning and fiber-dredging rich meal are input into brain cells and muscle cells in a human body, so that the energy is continuous, the energy is vigorous, the brain is kept clear, and the learning performance and the working efficiency are improved; the soybean oligopeptide, taurine and other antihypertensive substances contained in the health-care food can inhibit the activity of Angiotensin Converting Enzyme (ACE), inhibit cholesterol, reduce blood pressure and reduce blood fat; the dietary fiber nutrient contained in the product can be used for producing satiety in vivo, controlling appetite, reducing food intake, inhibiting gastric emptying time, delaying intestinal sugar absorption, inhibiting insulin secretion, stabilizing blood sugar, reducing blood lipid, controlling body weight, and preventing obesity.
2. By using the high potassium salt for cleaning blood and dredging blood as the seasoning salt, the problem of excessive sodium salt intake of hypertension patients is effectively solved
Under normal conditions, potassium in human cells and sodium outside of cells must be in balance with each other. In general, most of the foods in the nature are rich in potassium, so that the potassium nutrient taken by the human body is not deficient under normal conditions. However, if the human body takes too much sodium, the balance of potassium and sodium in the body is lost, and sodium can carry a lot of water into cells, so that potassium which is out of balance in the body can extrude the cells out of the body along with urine to be lost, and potassium deficiency in the body is caused.
In recent years, many scholars have studied the relationship between potassium and blood pressure, and as a result, potassium has been found to be negatively correlated with blood pressure. Clinical observation shows that potassium chloride can regularly reduce blood pressure, and sodium chloride can increase blood pressure. More significantly, the pressure reduction effect per mm/l potassium is 3 times the pressure increase effect per mm/l sodium. Some areas have salt replaced with "plant ash" (containing potassium chloride) compared to the original population, and they have very low blood pressure due to low sodium and high potassium diet, while the black people in the southeast of the united states have low potassium dietary habits, and the incidence of stroke is 18 times higher than the national level. Further research shows that the higher the sodium intake, the higher the blood pressure, the more people who die from hypertension, and the earlier the disease onset time in various age groups, and the systolic blood pressure can be effectively reduced by controlling the daily salt intake. Therefore, the choice of changing the "sodium salt" which raises blood pressure to the "potassium salt" which lowers blood pressure smoothly is clever for hypertensive patients.
The blood-purifying and blood-circulation-promoting high-potassium salt is used as seasoning salt, the potassium chloride contained in the blood-purifying and blood-circulation-promoting high-potassium salt can control the problem of overhigh sodium salt intake of a hypertension patient, and simultaneously, the originally overhigh sodium salt in cells in vivo is extruded out of the cells through the antagonistic action of potassium and is discharged out of the body along with urine, so that the blood pressure is reduced, the heart is protected, and stroke is prevented; the magnesium contained in the composition can expand blood vessels, reduce cholesterol, protect the blood vessels to be smooth and prevent arteriosclerosis; the dietary fiber contained in the food can control the secretion of large amount of postprandial insulin, inhibit the digestion and absorption of saccharide and cholesterol, regulate blood sugar and blood lipid, regulate gastrointestinal function, improve intestinal flora, alleviate poisoning and diarrhea caused by harmful substances, and prevent constipation, thereby further controlling body weight and preventing obesity.
3. The nutrition supplement is prepared by the blood-purifying and blood-dredging multi-vitamin tablets, so that the nutritional deficiency of the dinner diet is effectively compensated
The blood-purifying and blood-dredging multivitamin tablet is used as a nutrient supplement, and vitamins, mineral nutrients and antioxidant nutrients contained in the blood-purifying and blood-dredging multivitamin tablet make up the nutritional defect of a dinner diet, enhance the activity of insulin, promote energy metabolism, accelerate fat combustion and reduce fat deposition in a body; the antioxidant nutrients contained in the health-care food can inhibit active oxygen, eliminate free radicals, prevent acidification of body and blood deterioration, prevent arteriosclerosis, promote blood circulation, resist cancer and diseases, resist aging and prolong life.
Fourthly, the patients with hypertension do not need to take medicine for life
1. Major pathogenic factor of hypertension
Hypertension is the result of long-term interactions between genetic factors (internal causes) and external factors (external causes), and an adverse lifestyle plays an extremely important role in the onset of hypertension. It is currently believed that the following factors are closely related to the onset of hypertension:
body weight disorders, including overweight and obesity;
dietary nutrient imbalance, especially high (sodium) salt, low potassium, low calcium, high saturated fatty acid, high cholesterol, low high quality protein, low antioxidant vitamin, low monounsaturated fatty acid, etc.;
smoking; long-term heavy drinking, especially hard liquor;
a long-term lack of exercise;
long-term mental stress, anxiety, etc.
Modern medicine has demonstrated that lifestyle changes can indeed play a role. Can be used as the first choice for treating some diseases.
2. The antihypertensive drug itself does not treat the disease
At present, many people do not know the real effect of the antihypertensive drug, and only take the antihypertensive drug in case of diseases, the antihypertensive drug is not used for treating the diseases per se, only one mechanism can be controlled by using the antihypertensive drug alone, only symptoms are improved, and the effect of stopping the drug disappears. If the nutrition condition of the body is not improved, the pressure-increasing factors in the body are not discharged, once a human body suffers from hypertension, the normal level of the blood pressure can be maintained only by continuously taking the medicine for a whole life.
3. The dietary therapy can make up for the medical defects
The invention combines the food comprehensive treatment and the integral food therapy of hypertension and complications thereof through the light integration of blood purification and toxin expelling, and the blood pressure reducing factors contained in the food comprehensive treatment and the integral food therapy of hypertension and complications thereof are as follows:
(1) the enriched dietary fibre inhibits the absorption of cholesterol and helps to expel cholesterol, prevent arteriosclerosis, promote the smooth blood flow (see the above description for details);
(2) the enriched mineral potassium excretes excessive sodium salts in the body, regulating the balance of potassium and sodium in the body, and thereby lowering blood pressure (see the above description for details);
(3) the soybean oligopeptide rich in the soybean oligopeptide inhibits the activity of Angiotensin Converting Enzyme (ACE), prevents the contraction of the periphery of blood vessels, and reduces the blood pressure;
(4) the enriched taurine can inhibit sympathetic nerve tension (i.e. inhibit mental stress), reduce secretion of vasoactive substances such as catecholamine in blood, prevent angiosclerosis, and reduce blood pressure;
(5) the rich magnesium is a famous anti-stress mineral substance, and the calcium and taurine which are rich in the invention are matched to be a natural sedative, so that the health-care tea has the effects of protecting nerves, reducing the bad emotional stimulation such as worry, sadness, anxiety, dysphoria, tension, insomnia and the like, and being beneficial to maintaining the normal function of a high-grade nerve center, thereby reducing the blood pressure;
(6) when calcium is insufficient, not only osteoporosis which makes bones brittle is caused, but also arteriosclerosis, hypertension and diabetes mellitus are generated. The calcium enriched in the invention prevents arteriosclerosis, thereby being beneficial to reducing blood pressure;
(7) the rich coenzyme Q10 is a strong oxidative metabolism catalyst, can be called as 'heart power pill', enhances the function of myocardial metabolism, improves the beating efficiency of the heart, protects the heart, and can also reduce blood pressure, stabilize blood sugar, control weight and resist cancers;
(8) the vitamin B is rich2Can decompose fat, prevent arteriosclerosis and obesity, and is beneficial for lowering blood pressure;
(9) the rich chromium is a component of glucose tolerance factor, enhances the activity of insulin, simultaneously promotes fat consumption, reduces cholesterol, prevents fat deposition, maintains the normal level of serum cholesterol and triglyceride, and is beneficial to reducing blood pressure;
(10) the rich magnesium reduces the cholesterol content in blood, protects the smooth blood vessels and is beneficial to reducing blood pressure;
(11) the enriched vitamin C promotes the health of the capillary and prevents cardiovascular diseases;
(12) the enriched vitamin E can reduce blood lipid, prevent arteriosclerosis and improve blood circulation;
(13) the rich antioxidant nutrients inhibit active oxygen, eliminate free radicals, prevent acidification and blood deterioration, prevent arteriosclerosis, and promote blood circulation … …. These are blood "cleansers" and blood vessel "doctors", and are also blood pressure lowering factors and active ingredients that cannot be adequately obtained by medical means, daily diet and ordinary food. The substances enter the body to regulate the nutrition of the body, clean extravasated blood garbage and toxin in blood, discharge the pressure-raising factor, purify the blood, promote the blood circulation, reduce the blood pressure, relax the human body and eliminate the sound and the track of hypertension.
If a patient is a hypertension patient, the light patient can start from the food therapy (the blood-purifying and toxin-expelling food therapy), the heavy patient can be combined with the medicine therapy and the food therapy, the medicine therapy can overcome emergency, the food therapy can make up for medical defects, nutrition can be supplemented, the physique can be enhanced, the disease resistance can be enhanced, the pressure-boosting factor can be eliminated, the symptoms and root causes can be treated, multiple effects are combined, and the hypertension is effectively controlled. After the blood pressure level and other biochemical indexes are recovered to be normal, the dosage of the medicine is gradually reduced, on the basis of maintaining food therapy, smoking cessation and drinking limitation are performed simultaneously, the amount of exercise is increased, optimistic emotion and healthy life style are kept, and finally the medicine taking can be stopped, so that the trouble that the hypertension patient takes the medicine for life is effectively solved.
The detailed operation of the blood-purifying and toxin-expelling dietotherapy
1. Control the total heat of daily meal
The daily diet total calorie control is a metabolic syndrome crowd, the calorie consumption required by a human body is estimated and predicted in the diet therapy period, and then the food calorie supplied by daily diet is lower than the actual consumed calorie, so that the body is in a low-calorie nutritional state. The total calorie control range is 60-100% of normal calorie supply according to the daily diet of overweight and obesity.
Example (b):
according to the overweight and obesity degree and the activity intensity, a weight-losing plan is firstly made, and the total calorie reference intake of a daily meal is determined to be controlled:
table nine adults control daily meal Total caloric intake reference (kilocalories/kilogram-day)
Grade of obesity | Extremely light physical strength | Light body strength | Middle-strength power | Heavy physical strength |
Mild obesity | 25-30 | 30-35 | 35-40 | 40-45 |
Moderate obesity | 20-25 | 25-30 | 30-35 | 35-40 |
Severe obesity | 15-20 | 20-25 | 25-30 | 30-35 |
When the calorie is specifically quantified, the ideal weight is calculated firstly, and then the calorie is calculated according to the ideal weight:
for example, wangzhi, male, age 40, height 175 cm, weight 95 kg, occupation: and (4) a manager.
Ideal weight 175-105-70 (kg)
Obesity degree (95-70)/70 x 100% ═ 36% (belonging to middle obesity, light strength)
BMI=95/1.752=31.02
Caloric intake: 70 × 25-70 × 30-1750-2100 kcal
2. The blood-purifying and blood-dredging fiber-enriched meal is taken as an auxiliary meal, and a few meals and a plurality of meals are carried out:
after the ideal proportion for controlling the total heat of daily meals is calculated, the traditional three meals a day are changed into five meals a day, and one clean blood circulation-promoting and fiber-enriched meal is added between the original breakfast and lunch and between the lunch and dinner to be used as an auxiliary meal to carry out a short meal and a long meal. The heat of each auxiliary meal is 100 kcal, the auxiliary meal time is about 1-1.5 hours before lunch and dinner, and the ratio of the heat of each meal to the total heat of the whole day is reasonably distributed:
breakfast caloric ratio of 30%;
the morning auxiliary meal calorie ratio + lunch calorie ratio is 40%;
the afternoon meal calorie ratio + dinner calorie ratio is 30%;
for example, Wangzhi, moderate obesity, hypertension with complications, and a total daily meal calorie of 1900 kcal are still exemplified:
breakfast calories are: 1900 Kcal x 30% ═ 570 Kcal
Morning meal calories are: 100 kilocalorie (Jingxuetong Fuweimeal No. 3 1/2 of formula)
Lunch calories are: (1900 kcal x 40%) -100 kcal-660 kcal
The aftermeal calories are: 100 kilocalorie (Jingxuetong Fuweimeal No. 3 1/2 of formula)
The dinner calorie was: (1900 kcal × 30%) -100 kcal ═ 470 kcal
3. Ideal meal diet formula (daily reference intake): two grains 5.5, two vegetables 10, two fruits 5, two livestock and poultry meat 0.5, two eggs 0.5, two fish and shrimp 1, two bean curd 2 and two vegetable oil 0.4, wherein the total is as follows: the total heat energy of dinner is 1700 kcal.
4. The blood circulation-cleaning high-potassium salt is used as seasoning salt, the intake of sodium salt is controlled, and the balance of potassium and sodium in the body is adjusted:
during the dietotherapy period, 14.8 g (three parts in equal amount, one part for each meal) of the blood-purifying and high-potassium salt of the A-type formula (other types of formulas can also be taken) is taken by each person every day, and then common salt (sodium chloride) is added for 5 g (or less than 5 g) every day, and the high-potassium and low-sodium diet is adopted for seasoning. The high-potassium low-sodium diet seasoning method can supplement 4 g of potassium, 2 g of sodium (5 g of common salt is equivalent to 2 g of sodium), 0.1 g of magnesium and 6 g of dietary fiber every day for each person, so that the excessive intake of sodium salt can be controlled, the balance of potassium and sodium in the body can be adjusted, the salty taste requirement of the people can be met, meanwhile, the insufficient dietary fiber nutrient in dinner diet can be supplemented, and the seasoning method can be multifunctional with one salt.
5. The blood-cleaning and blood-dredging multi-vitamin tablet is used as a nutritional supplement to regulate the nutrition of the organism:
during the dietotherapy, the blood-purifying and blood-dredging multi-dimensional tablet (No. 3 intensified formula) is selected to be divided into three parts in equal quantity, one part (tablet or granule) is taken immediately after each meal to regulate the nutrition of the organism, and after the biochemical indexes of blood pressure, blood sugar, blood fat and the like in the body are improved and recovered to be normal, the blood-purifying and blood-dredging multi-dimensional tablet of the basic formula is used to consolidate the dietotherapy effect and keep the health.
Sixth, the dietetic therapy scope
The application and the function of the blood-purifying and toxin-expelling integrated light combination food in the food therapy are only listed in the specification, different formulas and different combinations of the blood-purifying and toxin-expelling integrated light combination food are selected according to different formulas of different people, and the food therapy range of the food therapy food comprises the food therapy and health care of various chronic diseases related to nutrition, such as obesity, diabetes, hypertension, hyperlipidemia, coronary heart disease, liver disease (fatty liver), gastrointestinal diseases (constipation) and the like, as well as the dangerous people with metabolic syndrome and metabolic syndrome.
Seventh, food therapy mode
According to different symptoms and the nutrition regulation needs of different people, different formulas of combined food and different food therapy modes are adopted, and the food therapy modes comprise: a dietetic therapy in which a small nutritional unit is taken alone, such as a blood-purifying and fiber-enriching meal or a blood-purifying and high-potassium salt taken alone; the dietotherapy that the two small nutrition units are combined and eaten in a matching way, such as the combination of the blood-purifying and fiber-enriching meal and the blood-purifying and high-potassium salt, or the combination of the blood-purifying and fiber-enriching meal and the blood-purifying and multi-vitamin tablet; the three small nutrition units are combined to be eaten in a matching way, such as a blood-purifying and fiber-enriching meal, a blood-purifying and high-potassium salt and a blood-purifying and vitamin-removing tablet.
Claims (6)
1.A blood-purifying and toxin-expelling combined food is characterized in that: the blood-purifying and toxin-expelling combined food is a meal rich in cellulose and high-potassium salt; alternatively, a combination of cellulose-rich meals, high potassium salt and vitamin-rich tablets; the food comprises a vitamin-rich tablet which is composed of cellulose-rich meal, high potassium salt with high potassium content and multiple vitamin minerals, and is used as three small nutrition units according to the nutrition regulation needs of different people: two small nutrition units are matched for eating, and the two are combined together, and the dietary fiber is supplemented for each person every dayThe charging amount reaches 8-17 g; or adding vitamin B into the mixture1Vitamin B2Vitamin B6The supplement amount of each person per day reaches 1.5-4.5 mg respectively, and the content of trace element chromium reaches 20-250 micrograms; the three nutritional small units are matched for eating in a quantitative combined package, so that the three nutritional small units are combined, the daily supplement amount of dietary fiber reaches 8-17 g, and vitamin B is added1Vitamin B2Vitamin B6The daily supplement amount of each person reaches 1.5-4.5 mg respectively, and the daily supplement amount of the trace element chromium reaches 20-250 micrograms;
in the formula of the daily consumption of each person of the meal rich in cellulose, the protein content accounts for 15-20% of the total calories of the meal; the fat content accounts for 20-30% of the total calorie; the carbohydrate content is 55-65% of the total calories; the content of dietary fiber is 3-9 g; vitamin B1Vitamin B2Vitamin B6The content of the chromium is 0.2-1.5 mg respectively, and the content of the trace element chromium is 10-30 micrograms;
in the formula of the daily edible amount of the high potassium salt for each person, the ratio of potassium: magnesium: the weight ratio of the dietary fiber is 3-6: 0-0.15: 3-9;
in the strengthening formula of the vitamin-rich tablet, the vitamin B is added into the strengthening formula of the daily eating amount of each person1Vitamin B2Vitamin B6The content of the vitamin E is 1.5-30mg, the content of the vitamin C is 100-500mg, the content of the vitamin E is 10-300mg, the content of the mineral selenium is 25-50 mu g, the content of the mineral chromium is 20-250 mu g, and the content of the brownish black hormone is 0-3 mg; the amount of other vitamins and minerals is less than the amount of other vitamins and minerals according to the conventional standard recommended by the Chinese academy of nutrition; in the formula, the brown black hormone is independently added into tablets or granules taken after dinner;
the cellulose-rich meal is one of formulas from No. 1 to No. 5, and is concretely as follows:
(1) meal formula 1 rich in cellulose;
according to the daily intake of each person divided into two times, the weight of spirulina is 4 g, the weight of defatted soybean is 10 g, the weight of konjac fine flour is 6 g, the weight of buckwheat is 34.5 g, the weight of corn germ oil is 4.5 g, the weight of L-carnitine is 1 g, the weight of thiamine is 0.171 mg, the weight of riboflavin is 0.355 mg, the weight of pyridoxine is 0.4 mg, the weight of ascorbic acid is 30mg, the weight of cholecalciferol is 0.7 microgram, the weight of tocopherol is 4.82 milligrams, the weight of folic acid is 21 microgram, the weight of chromium is 30 microgram;
(2) meal 2 formula rich in cellulose;
the daily intake of each person is divided into two times: 6 g of defatted milk powder, 12 g of wheat germ, 4 g of konjac powder, 30 g of pumpkin powder, 3.66 g of rice bran oil, 1.57 g of safflower oil, 0.3 g of maltitol, 0.15 mg of thiamine, 0.4 mg of pyridoxine, 28 mg of ascorbic acid, 0.7 microgram of cholecalciferol, 21 microgram of folic acid and 30 microgram of chromium;
(3) meal formula 3 rich in cellulose;
according to the daily intake of each person divided into two times, 2.0 g of soybean oligopeptide, 9 g of sesame, 6 g of konjac powder, 41 g of oat, 0.8 g of safflower, 300mg of taurine, 0.25 mg of thiamine, 0.32 mg of riboflavin, 0.4 mg of pyridoxine, 30mg of ascorbic acid, 1 microgram of cholecalciferol, 4.34 mg of tocopherol, 21 microgram of folic acid and 30 microgram of chromium;
(4) meal formula 4 rich in cellulose;
23 g of defatted milk powder, 21 g of honey, 9 g of tuckahoe, 0.8 g of safflower, 5.5 g of sesame oil or other functional grease, 0.5 mg of thiamine, 0.17 mg of riboflavin, 0.6 mg of pyridoxine, 25 mg of ascorbic acid, 3.75 mg of cholecalciferol, 5.23 mg of tocopherol, 20 mg of folic acid, 1.05 mg of zinc, 5.8 mg of selenium, 26 mg of chromium and 1000.mg of L-carnitine according to the amount eaten by each person twice a day;
(5) meal formula 5 rich in cellulose;
according to the daily eating amount divided into two times for each person, 13 g of black beans, 36 g of black rice or the sum of 24 g of black rice and 12 g of polygonum multiflorum, 6 g of black sesame seeds, 3 g of laver, 4.7 g of konjac powder, 0.8 g of safflower, 0.21 mg of thiamine, 0.262 mg of riboflavin, 0.4 mg of pyridoxine, 25 mg of ascorbic acid, 1.1 microgrammes of cholecalciferol, 21 microgrammes of folic acid and 30 microgrammes of chromium;
the high potassium salt formula comprises the following components:
70 g of potassium chloride with 47.55 wt% of potassium content, 0.83 g of magnesium, 50 g of corn fiber or other dietary fiber with 80% of dietary fiber content, 3.0 g of sodium glutamate, 1.0 g of calcium phosphate, 0.2 g of stevioside and 1.5 g of citric acid;
the formula of the vitamin-rich tablet comprises the following components:
the oral liquid is taken by three times per day, wherein the dosage is 2.6 mg of thiamine, 3.9 mg of riboflavin, 2.6 mg of pyridoxine, 6 mg of cyanocobalamin, 170 mg of ascorbic acid, 4.3 mg of cholecalciferol, 91 mg of tocopherol, 129 mg of folic acid, 359.7 mg of calcium, 2.2 mg of iron, 6.53 mg of zinc, 28 mg of selenium, 170 mg of chromium and 13.2 mg of inositol.
2. The blood-purifying toxin-expelling composite food according to claim 1, characterized in that: in the formula of the high-potassium salt, a potassium chloride debitterizing flavoring agent is added, and the debitterizing flavoring agent comprises: adding liquiritin 0.04-0.25 wt% or liquiritigenin juice to potassium chloride; or adding 0.02-0.125 wt% of sweet stevia or sweet stevia juice into potassium chloride; or 0.01-0.3 wt% of sodium cyclamate or acesulfame potassium artificially synthesized sodium cyclamate or corresponding amount of sweet juice is added into potassium chloride; adding 0.5-3 wt% of malic acid, citric acid, tartaric acid or succinic acid into the above mixture; adding 0.5-10 wt% of sodium glutamate, sodium inosinate or sodium adenylate into the above mixture.
3. The processing method of the blood-purifying toxin-expelling combined food as claimed in claim 1, wherein:
the processing method of the meal rich in cellulose comprises the steps of respectively processing required protein food raw materials, carbohydrate food raw materials and dietary fiber food raw materials into edible food blanks by frying, baking or puffing and curing processes before forming, then adding functional grease, a nutrition enhancer and an excipient for mixing together, and processing into nutritional auxiliary meals with different forms of cake-shaped, sheet-shaped, granular or powdery granules by adopting the traditional pressurizing production process;
the processing method of the high potassium salt comprises the steps of heating, baking and frying potassium chloride, spraying the debitterized sweetening agent while stirring to enable the debitterized sweetening agent to be attached to the surfaces of potassium chloride particles, cooling, drying, adding the flavoring agent and other components, and uniformly stirring to prepare the high potassium salt; or adding bitter taste removing agent, magnesium mineral and dietary fiber into potassium chloride according to different formulas, and mixing;
the processing method of the tablet rich in vitamins comprises the steps of fully mixing various required vitamins and mineral raw materials, adding an excipient, and forming by adopting the traditional tabletting and granulating processes.
4. The use of a blood-purifying toxin-expelling combined food according to claim 1, wherein: the food is a quantitative combined package convenient for carrying and eating.
5. Use of a blood-purifying toxin-expelling combined food according to claim 4, characterized in that: dividing the cellulose-rich meal which is eaten twice a day by each person into two parts in equal amount, and packaging the two parts into one small nutritional unit packaging product which is convenient to carry and eat, purifies blood and expels toxin, and ensures that the content of dietary fiber in the small nutritional unit packaging product is (3-9)/2 g; or,
the high-potassium salt which is seasoned and eaten by three times a day is equally divided into three parts, and the three parts are packaged into one meal, and the one meal carries a convenient small nutrition unit small package product for purifying blood and expelling toxin, so that the content of potassium element in the small nutrition unit small package product is (3-6)/3 g, and the content of dietary fiber in the small nutrition unit small package product is (3-9)/3 g; or,
the cellulose-rich meal which is eaten twice a day by each person is divided into two parts in equal amount, the vitamin-rich tablets which are eaten three times a day by each person are divided into three parts in equal amount, the three parts are respectively packaged into small packages of one meal and one part, then two small nutrition units consisting of five small packages are packaged into a small nutrition unit combined package product which is convenient to eat and contains two small nutrition units of the cellulose-rich meal and the vitamin-rich tablets, and the two small nutrition units are combined together to ensure that the vitamin B in the small nutrition unit combined package product is contained1Vitamin B2Vitamin B6The content of the chromium is 1.5-4.5 mg respectively, and the content of the trace element chromium is 20-250 micrograms; or,
each person divides the cellulose-rich meal which is eaten twice a day into two parts in equal amount, each person divides the high-potassium salt which is eaten by seasoning three times a day into three parts in equal amount, the three parts are respectively packaged into small packages of one meal and one part, then two small nutrition units consisting of five small packages are packaged into a small combined packaged product of two small nutrition units which is convenient to eat, contains the cellulose-rich meal and the high-potassium salt, and the two small nutrition units are combined together for one day, so that the content of potassium element in the small combined packaged product reaches 3-6 g, and the content of dietary fiber reaches 8-17 g; or,
the cellulose-rich meal which is eaten twice a day by each person is divided into two parts in equal amount, the high-potassium salt which is eaten after seasoning for three times a day by each person is divided into three parts in equal amount, and the vitamin-rich tablets which are eaten three times a day by each person are divided into three parts in equal amount; respectively packaging into small packages of one meal and one portion, then packaging three small nutrition units consisting of eight small packages into one bag, bag or box per day for carrying a convenient meal rich in cellulose, high potassium salt and a tablet rich in vitamin, and combining the three small nutrition units to obtain a combined packaged product, wherein the potassium content is 3-6 g, the dietary fiber content is 8-17 g, and the vitamin B is1Vitamin B2Vitamin B6The content of the chromium-containing trace element reaches 1.5-4.5 mg respectively, and the content of the trace element chromium reaches 20-250 micrograms.
6. Use of a blood-purifying toxin-expelling combined food according to claim 4, characterized in that: the high-potassium salt powdery product which is seasoned and eaten by each person three times a day is directly packaged into a small nutrition unit quantitative bulk product with a measuring cup or a measuring spoon and an eating instruction of one cup or one spoon, so that the dietary therapy supply amount of potassium element in the bulk product is 3-6 g per person a day, and the dietary therapy supply amount of dietary fiber in the bulk product is 3-17 g per person a day.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2008102290573A CN101473953B (en) | 2008-11-26 | 2008-11-26 | Fabricated food for cleaning blood and expelling toxin as well as method for processing the same and application |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2008102290573A CN101473953B (en) | 2008-11-26 | 2008-11-26 | Fabricated food for cleaning blood and expelling toxin as well as method for processing the same and application |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101473953A CN101473953A (en) | 2009-07-08 |
CN101473953B true CN101473953B (en) | 2013-03-13 |
Family
ID=40834816
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2008102290573A Expired - Fee Related CN101473953B (en) | 2008-11-26 | 2008-11-26 | Fabricated food for cleaning blood and expelling toxin as well as method for processing the same and application |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101473953B (en) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101849642B (en) * | 2010-05-25 | 2012-07-25 | 西安力邦临床营养有限公司 | High-energy instant food |
CN101869300A (en) * | 2010-06-11 | 2010-10-27 | 浙江省医学科学院 | Bee glue and perilla herb oil health-care food for assisting blood fat lowering and preparation method thereof |
CN102160616A (en) * | 2011-03-11 | 2011-08-24 | 李建华 | Food formula special for patients suffering from diabetes and preparation method thereof |
CN102847159A (en) * | 2011-06-29 | 2013-01-02 | 智乐斯科学有限公司 | A glucose metabolism enhancer |
CN103005403A (en) * | 2011-09-20 | 2013-04-03 | 马建领 | Enzyme dietary therapy liquid for removing toxins in human body, and preparation method thereof |
CN102894311B (en) * | 2012-10-31 | 2015-01-14 | 湖北天利达科技有限公司 | Arrowroot with function of health care and preparation method thereof |
CN103349051A (en) * | 2013-06-17 | 2013-10-16 | 南阳市新天地生物科技有限公司 | Biscuits suitable for hyperlipoidemia crowd |
CN103750399A (en) * | 2014-01-20 | 2014-04-30 | 周维官 | Sea cucumber protein nutrient and healthy food |
CN104055109A (en) * | 2014-05-29 | 2014-09-24 | 胡安然 | Special diet with functions of reducing high blood pressure, high blood fat and high blood sugar and tonifying Yang |
CN104286756A (en) * | 2014-11-06 | 2015-01-21 | 天津天绿健科技有限公司 | Weight-losing fruit and vegetable powder |
CN104381884A (en) * | 2014-11-06 | 2015-03-04 | 天津天绿健科技有限公司 | Preparation method of weight-reducing fruit and vegetable powder |
CN104305054A (en) * | 2014-11-06 | 2015-01-28 | 天津天绿健科技有限公司 | Seasoning fruit and vegetable powder |
CN104351792B (en) * | 2014-11-22 | 2016-06-22 | 杨高林 | It is specifically designed for the manufacture method of the maternal nutritional powder of pregnant early stage |
CN105483234A (en) * | 2015-12-26 | 2016-04-13 | 上海中优生物高科技有限责任公司 | Hypertension-type obese gene individualization intervention composition and preparation method and system |
CN106912922A (en) * | 2017-02-15 | 2017-07-04 | 丽水市柏晖健康管理有限公司 | Liver and gall intestines decontamination formula and purification method |
JP2022546966A (en) * | 2019-09-05 | 2022-11-10 | ソシエテ・デ・プロデュイ・ネスレ・エス・アー | Food composition for lactating women |
CN112826872A (en) * | 2021-01-15 | 2021-05-25 | 尼腾(广州)生物科技有限公司 | Composition for expelling toxin and losing weight in stomach and intestine and application thereof |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1943426A (en) * | 2006-11-20 | 2007-04-11 | 高志强 | Quantitative packaging unit combined food containing specific nutrition component ratio suitable for diabetic, sugar regulating injured person and diabetes high risk group |
-
2008
- 2008-11-26 CN CN2008102290573A patent/CN101473953B/en not_active Expired - Fee Related
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1943426A (en) * | 2006-11-20 | 2007-04-11 | 高志强 | Quantitative packaging unit combined food containing specific nutrition component ratio suitable for diabetic, sugar regulating injured person and diabetes high risk group |
Non-Patent Citations (1)
Title |
---|
于康.《糖尿病的营养治疗》.《糖尿病的营养治疗》.科学技术文献出版社,2003, * |
Also Published As
Publication number | Publication date |
---|---|
CN101473953A (en) | 2009-07-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101473953B (en) | Fabricated food for cleaning blood and expelling toxin as well as method for processing the same and application | |
CN101744170B (en) | Tartary buckwheat eight ingredient porridge suitable for patients with diabetes and preparing method thereof | |
CN104643250B (en) | It is a kind of can bidirectional modulation body weight improve inferior health solid beverage | |
KR101738912B1 (en) | Composition For Anti-obesity And Diet | |
CN102813120B (en) | Anti-cancer sea cucumber sugar-reducing flour and preparation method thereof | |
CN102511869B (en) | Thickened red jujube ginger pulp | |
CN101156685A (en) | Health-care nutritive mush | |
WO2011060585A1 (en) | Chewable tablets including essences of five-colour fruits and vegetables and preparative methods thereof | |
CN108719984B (en) | Meal replacement nutrition bar for gout population and preparation method thereof | |
CN101507494A (en) | Special diet food for patient with hyperlipidemia and hypertension | |
CN105211687A (en) | A kind of composition and method of making the same and purposes | |
CN106107463A (en) | Super Quinoa Antifatigue milk tea processing technology | |
CN102197837B (en) | Sea buckthorn fiber biscuits | |
CN109329930A (en) | A kind of composition and preparation method thereof for promoting uric acid to reduce | |
CN108391785A (en) | A kind of functionality meal replacement powder and its manufacture craft and application | |
CN106722148A (en) | A kind of stomach maintenance eight-treasure cake and preparation method thereof | |
CN110574862A (en) | Nutritional weight-losing meal replacement powder suitable for teenagers and children and preparation method thereof | |
CN104856000A (en) | Non-complete-nutrition formula food for insomnia | |
CN102228117B (en) | Chicory tea | |
CN102090637A (en) | Collagen-containing compound nutritious powder | |
CN103461779B (en) | Multifunctional green food grains other than rice and wheat | |
CN115553406A (en) | Weight-reducing composition beverage for inhibiting absorption of fat and sugar substances and preparation method thereof | |
CN102048134A (en) | Five-material vegetable nutraceutical and preparation method thereof | |
CN108208813A (en) | A kind of weight-reducing with health role disappears fat piece and preparation method thereof | |
CN113842452A (en) | Medicine composition for treating diabetes and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20130313 Termination date: 20151126 |
|
CF01 | Termination of patent right due to non-payment of annual fee |